{
  "meta": {
    "title": "Pediatrics_Test_I",
    "url": "https://brainandscalpel.vercel.app/pediatrics-test-i-ce4f969c.html",
    "scrapedAt": "2025-11-30T12:48:10.161Z"
  },
  "questions": [
    {
      "text": "A healthy child is able to stand with support. Which of the following fine motor milestones is attained at this age?",
      "choices": [
        {
          "id": 1,
          "text": "Immature pincer grasp"
        },
        {
          "id": 2,
          "text": "Mature pincer grasp"
        },
        {
          "id": 3,
          "text": "Reaches for objects with one hand"
        },
        {
          "id": 4,
          "text": "Reaches out for object with two hands"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A Child stands with support at 9 months, fine motor milestone attained at this age is immature pincer gap.</p>\n<p>Developmental progression of grasp:</p>\n<ul>\n<li>6 months &ndash; Baby reaches and holds a larger object in a crude manner using ulnar aspect of his hand <strong>(ulnar palmar grasp).</strong></li>\n<li>8-9 months - Object grasped by radial side of palm <strong>(radial palmar grasp).</strong></li>\n<li>9 months - <strong>Immature pincer grasp</strong> develops. Object secured between adducted thumb and extended index finger.</li>\n<li>12 months - <strong>Mature pincer grasp</strong> develops. Object secured between opposed thumb and tip of index finger.</li>\n</ul><hr><h3>Related Pearl: Gross motor milestones</h3><table><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>3 months</td>\n<td>Neck holding</td>\n</tr>\n<tr>\n<td>5 months</td>\n<td>Rolls over</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>Sits with support</td>\n</tr>\n<tr>\n<td>8 months</td>\n<td>Sits without support</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Stands with support</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>\n<p>Stands without support</p>\n<p>Creeps well</p>\n<p>Walks but falls</p>\n</td>\n</tr>\n<tr>\n<td>15 months</td>\n<td>\n<p>Walks without support</p>\n<p>Creeps upstairs</p>\n</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>Runs</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>Walks upstairs and downstairs (2 feet/step)</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>\n<p>Walks upstairs with alternate foot</p>\n<p>Rides tricycle</p>\n</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>\n<p>Walks downstairs with alternate foot</p>\n<p>Hopping on 1 foot</p>\n</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Can skip without falling to either side</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Fine motor milestones</h3><table><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>4 months</td>\n<td>Reaches out for objects with both hands (Bidextrous reach)</td>\n</tr>\n<tr>\n<td>\n<div>6 months</div>\n</td>\n<td>\n<div>Reaches out for objects with one hand (Unidextrous reach) and transfers objects</div>\n</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Immature pincer grasp</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>Mature pincer grasp</td>\n</tr>\n<tr>\n<td>15 months</td>\n<td>Imitates scribbling and builds a tower of 2 blocks</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>Scribbles and builds a tower of 3 blocks</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>Builds a tower of 6 blocks</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>Builds a tower of 9 blocks and copies a circle</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>Builds a bridge with blocks and copies a cross</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Copies a triangle and&nbsp;builds a gate with blocks</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4773a150d41047a29789e417bb2993e1x1280x936.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Developmental progression of the grasp</h3><p><strong>Ulnar palmar grasp</strong></p>\n<p>6 months: object is grasped by the ulnar side of the palm&nbsp;&nbsp;&nbsp;</p>\n<p><img class=\"WACImage SCX139599407\" src=\"data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAMCAgMCAgMDAwMEAwMEBQgFBQQEBQoHBwYIDAoMDAsKCwsNDhIQDQ4RDgsLEBYQERMUFRUVDA8XGBYUGBIUFRT/2wBDAQMEBAUEBQkFBQkUDQsNFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBT/wAARCAB2AKgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5qsIkh8rzP3kCR+Y//fH3d1WZb/7XF+8l8uPzEk3/APj1VppfOli2W0Um+P54/wDnn/CrVJ/rrW2TyovL8zy38z5Pk/8AZaALVrshtZY45f3fmeZ5cf8Ay8f71SWsXk3XmTyeZG/++7x7k+b5f96pf+escflfPs/49v78f3ali/ff8hKWXzP44/vzfL/DQBJ9g86L/npJ/q4fMl3pcOybf+A/NUsv7mw8j7TF5/yVetbW6hilk8rzdknyR/8Ajv3qi+wWvm+XHL9pk8t4/wDSYv8AV/e/vfeoALWK6u/NgtJfMj/1iSfx7Ff73+zRf/vvNj83zI/+ef8AB/tbWrY0u1S7iijk83yEk8x47aL/AFjs/wDe/wDH6o3Ur+b5flSxwWsj75Ln5P3P93/Z+7QBVtYrq7tfMtP9Ylv5cMf/AKDtZqltftU11FPJFF8knlyxyb0fZs+Zt38Tybv4avRWHk38X7qK503/AF/73enmf73T71SxWsH7qO7jijjS3edP4P8AWP8AjQBetbC1/dX9xL+78z5/LifZHu/usuflo8211Cwl8u2lsv3iRvH/AAbN/wA37xv/ANujVNeT7LL5csslv8n+siRP+Bf+z1FYSvd38Vp5ssthdfuPIj+R/wDx3+DdQBLay3V39hk8r7NAkfmQ+X8/yM/zbv8Ad3fxUf2W/wBq8uP/AFCfu3ST5E/2m/2v/i6JY57SW5g/4+Z0j8uaf538z+Fqvapaz6h5Ud3c2skc2+Tz4/uRuyb9qr/DQBj/AGqfUIoo4JfMk8z9zJ/y2jRk+Xc33a5/VL+91C68y08q5/d+XNJHLsS3+Tb5rf3tv9+uqll87yoJ4rWOOa3f7RJ8n8Xyfwr/AKr/AGKzJbDSIZfsn2mKPfH8/lS/JbpvZl+7/H/dSgDjNU2WkUVpJfeZaf6xPMiRPL/4EufkaqNhqnh7ULrzJLmKOR/3f+t2JHtT/lmv8Xy13Hij4I6J480v7IniW/t5PL/5dok2f7u2vItU/ZB8T2l0JNN8QWtz+7+WSSOWF0/3tuaAOuurrS/sHnwXMVlB5exIPK3pv/3q+o/2Vb+HUPhpfaTHLFHqVlqDx3EHmp9yT545dv8ADuWvjeH9mnxRDaxJceJfLk++/wBmsd6R/wDAjj+7W54S+FfjH4ZaxLq2m+KpfMmj8i4hksX2SJ97s3/stAH6HeKNZh8M6NFaQS/8s/MeSKXZ5n+zuor47sL/AMeXfmz6l9qk+/skji/1f+181FAHmvlfupf3v7zy/L/651pWsX2TzZ5P9J/ePvgkl/g/5Z/+PVyOjeKJ5rWKOSx/d/8ATP5KvReLb2GX93YxW37vy/MoA67ynh/eSSyx+Ts3/uv+WP3qlv7WfzopI/8AWXX7y4k8pE+992uVsPHmqQxeXJY2tzH/ANNP/wBmr0Xja6htfL+w/vE/dpJbbPuf/F0Adfa/uvKjg/eSeZ8/2aL+997d/wACrSitYJrqKSeWKS0m/cJP9z59ny/7VcP/AMJ5a+V+8sb+2j/j8y1f95WxF430uaWXzNX8vZH5cP2m13/eT7tAHSy2qQxR2kH7uT7Q8jpbS/6tPurUUX/Ew8r7XF/0z/4A3+982+s3S/EekeTfR/aYvIT95/Bv+VPvfd/vVesL/Tv3VpJLLHHqFw/k+V/y0T/Z3f7X8dAEnlWsMUUEksUkiXH+vj/5af3d3/kSqOqS2tpLLd+b+/8AM8/y5PnS3T7v3v7jf7NHijVLLT9Gl/0aXy0kfZPH/wAtE37d3zf9s68r17xakOl3NpHLL5774/8Avr/gXy0AdxpfiNIbry5LbzNn7zyJPv8A7z+7Xe2F15N1bTxy/aYPkkmnki2QyJH823av8a/36+XNL1mTT7+KCPzY5Pk87zPv/wB3duavZ9G8eWtp4cig/wCW7yeXv+dEkhX/AJZbV+b5qAOu1nZaebHptz/ZO+T5LqO6Tf8Aw/d3fd//AHlRS/ZYf+WV1bQeZ/ueYn95W+9vauM0vxlqn2qX97LJA++SaOWJE/gbbt/76rqtB8Oajrf+n3f8Eb3aQfwfc+9QB1/gjwRdfEiW5u55YrbSftnz/uvnk2/w/N/d+5vruL/4GaRp8XmWGmRRyJ+8SSP55v8AgVdL8PvCX9k+F9MtPN8uOG3TfHH/AMtH/i+aulv7BIYpY4/Nik/6Z/8ALP8AhoA8nsIrLQ7qKC7tvs0n8cflV6DoOjaXq2l+fBLFcwf89I65XxH4cj1aLy7jzbmBP+mtcr/Y2t+HpZZ9FvpdJ/74dP8AtpG33qAPZ5fDdr5X/HtFXM6zYWUN1F5kX7uuVk+OV74fsZY/EOhy/ZIf3b6lpP8ApKRps+aWSH/XJ/wHfV6PxlpfivS49S0rUrW8g+SdXtpUdP0oA6qXwl/oHmQReZ/1z/v0UfD7xba3dhF+9/dvvj8v+D+61FAHxvD4X8mL/c+5/uVFFoKQ/wDXOvS5bH91/wCgVRl0v91/v/foA8+k0v8Ae/u4v/iKT+xv3v8Ara7SXS3ml/1VWf7GeH/lr+8egDgotLntJf3f7uT/AD/eqzo/h3xB4l1yy0PTj9ovtTuEtbe1MafPLI+1a7m18OvN5Ve/fsb/AA0TUPiDc+KJIv3GhW7xw/uv+Xib5Fb5v7q+Y/8A37oA+d9T/Zb+Ifh/xlY6T4o8Pf2TaXV5DBNrHlJNZ+Sz/M32hFK/d/vV+nHiP4YeENc8C3On+IfD9hq2k/JBbwSR/wB3+JWX7u1f7tdNHE8MXlx/x/fj/wDiq5rWfhfpeuWEsFpc6p4ckeP5J/D915Pl7v8Api2YW/4FHQB+anxL/Z91HXNZ+IM/wy0iXXvBfhW4SC702S+d5o7iSLzZIoVZv3vlr/wOqOqfsR/FC78EWPiWPwZa61BdW6Tpa6bfedeQI3z/ADRtj/x2vp/Rf2H/AIlfDLWZP+EM+MMureE9Q1T+0tZ0PVrFLa5n8x/322YZj81v+AV9R3XjLSPCfhyWDUvN8OSPGkCR6vF5KfL/AHZv9W3/AH1QB+JN/appOqXMGpaZLZXcMnzwX0TpN/utvrMv9en/AOXSX7FH/BHH9yvur4q/Dnwv+1t8X/GcH/CVf2LqXhHT7OC3ntokm+1vM8ksnmLxuijVY/4v+WtfnzLYXU3iOTSbD/ibXf2x7SGOxid/tbq+3dGv3qAPoz4S6CniHS7GT/WIn7yaT/bV6+lfDnhJPsssflfvPL8tP++K8w+BnwV8eeHvBGkQPpFrp1388lx9ul3/AHn/ANjNeqRfBbxzrcX+l+OLqyj/AOeGk2KQp/30+WoA73QfsunxeZdy/wCgXtnDJ5kf/LP+CT/vlvLepNeuktLD95/rPMeN/K/v/LXmv/DL6Q/8feuazqP3/wDj51OXZJu+98q4X5qktf2c9B0+1itI7Hy4E+5+9lf+clAHo2l2trNL5H8dS694SS7tfMj/ANYn/s1cPpfw0uvD115mm311ZSf88/Nd0/75fNdfY+Lp9Jm8vXYoo4P+f6P7n/Av7tAHBX/g37Xf/uLmW2u0+5J/8VXkHxO/ZZs/EGn6le6WIfDXioRvPDqmnb7ZJ2XLbJo0+Xv9/bvr7B/sFNQtfPtJYvn/AHlc14o0Hyf3k8sskn/fH3f9mgD85/hL8c9X+E+tf2LrpupdJjvPLuIbn57mwlZ/mbd/Ev8Ae/8AHKK9++MnwN0/Vtei8WfYYrl4Pk1GDyv9fb/3v9+OigDSurD93/33vqt/Y3nSeZJLWvFvml8z+5/yzrTtbVKAMiLQUhqSLQU83/pp/B+6rporXzv9X+7k/jqT7B5MXmeV/wBNKAOfi0ZPKijkr7I/Z98JJ4T+F+kfuvLu9U/4mVx/f3yf6v8A8hrXy59g+1+b+9/d19EeEv2jE8qK013SP3aRpH9q0n/ln/D/AKtv/ZaAPavK/ff8svkq1FFWH4X8ZeHvGX/IF1e1vX/54fcm/wC/bfNXS/8ALP8A26AI/K/+wov/ALLaaXcyal+802G3eS78yLekkKpubcrVZ/6Z15T+054oHh/4ZSWCSR/a9cuPsQP8flKheT/0FE/GgD88vGvw9tdU+Ier+NfB5j+H+s6h9pj8nTov9D2S/L/qeNvy/wB2u9/ZL+CMPwt8IyeIYJbW51nULx7R3uYokudke39xCzt92uz8EfDSfx5qEtp5ssdhDH599dR/fjT/AGf9tq9si+Evh7Q9Bi03TdDitoEj/wCWkW95P95vvb6AKNh480uGXyNSiutOk/56fZXTy3/6aRrn5P8AbirX/tS6m8qSOx/cPH5iTxy70kRv92si1+1aT/ol/F9tsP4J4/vx/wC9XoHwrNtdX974an/dxyR/a7KT/wBGR/8As1AGTaxf2h/r4vv1FdaCn/72u41nwv8A2TLLJH/BJVHy0mtfM/5aUAcP/Y3/ACz8r/ppVa/8LwTRV3n2BIfNkj+5/wCyVHLa/uv+2fyf8CoA8rsbr/hA7qK0ki8zQnk2f9em7/2Su81nw5Bq1r5kcX7x/wDlnVbXtGS7il/deZv+/HXNeHPEb6TLF4eu/wDl1/eWMkn/AC0h/u/8BoA4vxRoP2SWWOT95H8/+5RXaa9s1D93/q3/ANXRQB8nWuqJ5X7z93J/z0rStdZ/1VcPFf1p2uspD/0zoA9BsNUSatP7V/2zrzmLWYP+etEvjeytIvMnuYo4/wDrqlAHby37+b+4l/d/xx/7FWotZ8mvNJfGU/2WWe0trq4jh+/JHF/8VVa117VNW83zLn7Fsjed4I9jzR7U/wBrCq9AHs/gOKDxN480PTX/AI7jzH8v5H+X5q+w9L1XUNQ8Zf2FY/urey/4+/N+f52Tdt+b+6tfnH4S1TXvAeveHvFk9zLc3dlePI+j/cm2fd+Zf7n+sr7b8MX17qXgOL+yrn7bq3jG82fbo/8Ank6ebM//AHz8tAHoMvxa8N6Tcy/2lexadpr3n2S31ST/AFNw6pubb/u/36+Yf2tPEXiXx58QdItPCeh6p4n0XSbdJLd9EtXmSd5PmkbzPu/881r648O/DXRYdDtpLvTbW41GON4EuriFXMC7/uru+7XT6THA2n/ZJ5IpRC7wIvl7Pu/L92gD5d+CPg3xr4e8OXP2v7Lp13e3CTzSRWvnPHtTasXzfL/FJXsWjaXdf6i/vrq5kT7nmS/J/wCO13F19i0m1/dxxRyeX5lcPf8AiOD7fL+9oA57xv4bg0/zZIP3Uf8A9hXBWuvP4T8WeHr9P3fk3kO//ckfypP/AB1q9L8R36TaX5kn7zf+8r548Zaz53iPSLGP/X3WoW0aR/8AbVaAPsPx3MkUP+5/HXnUV+/lSx/991F488eJd+b+98xP87a4e18R/wCt/e0Aeg/bv7/8FRy37/upP/IdcrFqnnf8tfMjqzLf+d8lAGndTJNFXl/xG0tLvS/Pji/0u1k8+GT/AKbLXe+a/lRfvf3lc94j/wCPDzP+WdAHP/b3vLC2u4JfvxpJ/wB9JRXIeDde+yX8uizy/u03yW//AFx3/d/4DuooA+LbWLVLSKKOO+v/APj4+SSTZs2bN27a3+1XQx6XezRW093q+qW0b/cg+yon2j5P733lrX8q11D93JF9pjT95+8l2PJt/wCWTY+6rfw10Ol7IdG8vyv9ETf9ngjiT/gO5vvf7FAHF2Ggpaa9LJd+VewJ+88iS6eb5/4V+b+7W5L4XsvEV1FJYWP7y6k8xLH5P3br/E3y/vdv/oFdD/Z/2v8AdwRWttaSW8Mlx5fm+dHt/u7q3NLtUtLGKPypfLh3xvJ5vySI33VXbnb/AMtN22gDI1TS0/tS2j+3S3N3NI/nXVzK7zRu3ybfM27Vej/hCLr/AEae0ilvbRLh4/3cqP5jq/3Vbb/n+CuguooLvVIvItv9dH8mmyS/Pv8Au/L/AN9V1UWyaL7XJFFHH/rJrqT5/wBzv+VY/wDnr/8AF0Aeff8ACG+dayxx3MVzP5aeTHHv2R+Z97zN7bt7fxV7N8L/ABve+A9UttJn+1SWCXn2u0kk/wCXd1+WRf8AckXzPu1y1rqn/HzJcaZ9mjhuPL8iT50k2u3zbl+87Ku//wBno1TZ9q+yR3322S9j8t55Ytnlo3zeV/d2f+yUAfb2g+NXu/FVzZXckVxpeoRQ3UXmfwbosNt/2dy1u6l4R1G6k32N9bafA/30jid8/wDj1fEnhf4l6v4Z+zWE/m3NpD+7SeTYj26fw7f76N/c/wC+K9+8G/tBWs1rLHJdfvE+/QB02qeF9bm1Ty5Nc/0f7O8j3UcXz71/+KqTRvhrov8AZcb3ct19uSR4Lif7T/rHX+LbXPy/Euy1C/i8i+ikjqLVPiNZaTayz39zFH9+TzPNoAveMvI0OwuZ5L6WTZH/AMtNn7v/AL5r4Iv/AIyXuofGSW/0zTP7RsNL3wW3+lfPJN/FKq7fmSNf469U+LXja6+IVrcwf2nLp2k/884/9dcJs/z8n8dcPpfhyHSdUlsIJfsWmvH5c3l/Olxt/wCWTfxL8zUAdLL481fXIv8AT7n+zp/LSRLWP998km5vmZfu7f3dXtL8W3Vpqn2COKXVpPn/AHlt/wAtNv8AEq1xkUVrq11FBafarKOGTY91HFveR/uq0nTdtjoilju/Nkkilst++BP9KdE+V/8AW+Z/00/ylAHsWg+PILuP93L5kn8ddVpevedXzTLqkE0Vz9ktv9Ltf3k11H9+4+T/AFu5fvf7lbnhLxvqkOsxWElt9p86RI4f3vzx/J/E20UAfS0V/wCbWP4juvOirg7Xx55Plef/AKFO8fmeXJ8n3v4qiv8Axanlf6395QBh+KNG+1/vI5fs13D+8hnj+/G9FZniPxlBaRfvJYo6KAPMLC/n/wCWlt9i326Rw/3/APrr/tPWnaxfZNLtrS0j8vzrd53j8ryX85X+Vqo2tgn+r+0y3M7/ALuGST/U/wDoP/jldLJ9lu4pZ7uKW9nS38t/+nj+FflX/vtf/H6AIvNe70u2nktvtt3N+8SOT5E2Rpt/+wqO12eVFP8Auvn3xzRxxf8AHu67fmX5v4vKko/sZJrqW7nl/wBT/wAsP+ej/wAS/wDoytzRvIhlljjtotRjupEkf97++/ef7O4bqAJIvI8qK4jluvPSP5/3T79ny7ovM+6u1fn+7WxFa2vm20clzLcz+X/o8dtap/6Ev/ff3qqyRPNFc+X+7u/L8v8A2LhP4tu6tPS7BPKsZ7S2lstkfmf63e8br/s7du+gCtYWEEsnkTy+XJNcQ75PNR03r8zbm/h/4FVG1sE+1efP/wATH7m/966fIqf6pd61euvPm1i5ksJftMc1x5lxPH8n+sdW/eVt6ppaWlhfR3/leZD9z7nkxp/eZf4n20ActqkT2kVtHPfRSRp/z7b9m9v7sf8AvVZ0vfpNhLHJLdfa5o/30cfzpsb7u7b/AB7Yv++6l8OXX2T959u+zSQ+TH/z2uZN3y/u1b5dm35Kiv4rWaL7XHFFsmkeR/L+R40Z22tt3UAWbWW1tIoo57aWT9588Hmu80m77u3q3/jtZtraz6hqksflS2U6SefDJ/yxjdfmX73y7FrpdLleGWK0+0y3OzZIk8e/fGi7du3dhtn+Xqj9vuppbnyJf+P2Py5vtO9EkhV/ur/D96gCjf6z5MN9BP8A6ua38jy49+y33P8AK3/Af/QKzIv3NrLO8sUck0aR/araJH8v/gK4k/266H7La2kv2v8Aexxv+88y2l3zfwru/uruqK6sLWGWLy/3cH2jy7ieT7ke1P4lb+P/AHaAMiXw4/8Aan2ST7Lp2pJHNG8nyI+9UX+FW2xIv8P9+q32Cy/tTzI5YtOsPMSdPMieZP73lbmx/wB8Ve16/TVrWKDyrWyknuHnt/Li3/wf6pevyVFN+5iuZLSL7TBDcfJJ/qYd7bl8/wAt8/3aAKN15/8Ap0En2W2nmkeNII7pHh3ru+6v8W1vu7fv1ysWvT2l/FPH5vkQ7JPLk+//AHl3fN/103V1WqaXaw6DL5kv7v54/wC/5bx/ebb/AHK5XRpoLS/8ueW6/fR+XcXUcSb49v8ACyn73+zQBW8eeLLrxDYRQWljL88fl+ZJs/hTc3/jtcFpeg/8Ibp8Wm2H7xP9Z+8l3/O3zfxZrvbWKDVvNntL6LzLW4T9/fRbH3/MvzKuWXctchrMs8Pm6b5v+gP/AKm6uYtj3D/w/wC7QAeV51h58n+jedcfJ/y8zRuvzL+7Vd3+6lFGg3Vlp+s6Zf6lY/2jaQ3kMl9B5rp9ot1/hXbiigD0ebT7nw/LeZaKThbcbS37pgnBTOcL7U7Q1aOae1mmkSCcNdfuDguy/cD+oFFFAHQ6LqEFq0N2tqq/YJZICgIKlQhwuCMFfmbrnrWldRf2PH5UVvbiW4uY4EJBKqpdsKQMfKe9FFAFzw7o765CbqLy4LZ7Z7qSNyzsUzjy8/T+LrVW0huNNBvbSdAjpFJEs0KuY3bocHI4oooAsRQr5jRx7TH5b7BIrHzvnA/e/Nz95unrVqTTX067miYW7QR248xfKzvzGpPTHeiigCGxu4LHQ2hg3syzRrE0safdPUNxTTpaTNdvHFHI9na7rmScsTMzHGVGcLxRRQBo32ky2U2niQxrA1qzfuSweRnfJMn97b/DnNQrqVtqouLnUEaCWSOLm0UlUwqsdgLgpgcrtYfNRRQBFrFrNeyW0aztCtzdLEZIgqZV48BjGqhAwHoBVC+0tLizWweKN7WHOHcsZHwMjdz60UUAW9S0K30iYiJZm0t0klaFZhHKEAyGVwmVkz3GKdfaSumyWtzfHfPeu6MtozRp5e3fsPP3sfLv/wDHKKKAMDULNZtNUSKGdo02zbm8w/J/E2c/rXOeLbP+xhDqMUgkijZ18ooFKrtxgY46e1FFAGXqOj2skF3q93bC5keOOORkk8pi7rtDYCkcP81cm9i1/cQ293KjmVVhd44dvmENkMVDYHPpRRQBz39oyHRr7E7f6PL5n+r+8/ryxooooA//2Q==\" /><span id=\"{93b8e9bb-15bb-42f8-a3b3-6a3f62bc91c3}{207}\" class=\"WACAltTextDescribedBy SCX139599407\"></span><img class=\"WACImage SCX139599407\" src=\"data:image/jpeg;base64,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\" /></p>\n<p><br /><span id=\"{93b8e9bb-15bb-42f8-a3b3-6a3f62bc91c3}{207}\" class=\"WACAltTextDescribedBy SCX139599407\"></span></p>\n<p><strong>Radial palmar grasp </strong></p>\n<p>8-9 months: object is grasped by the radial side of the palm&nbsp;&nbsp;&nbsp;&nbsp;</p>\n<p><img class=\"WACImage SCX220550837\" src=\"data:image/jpeg;base64,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\" /><img class=\"WACImage SCX215536996\" src=\"data:image/jpeg;base64,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\" /></p>\n<p>&nbsp;</p>\n<p><strong>Immature pincer grasp </strong></p>\n<p>9 months: the object is secured between the adducted thumb and the extended index finger&nbsp;</p>\n<p><img class=\"WACImage SCX155962968\" src=\"data:image/jpeg;base64,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\" /><span id=\"{565e58e0-a27f-4721-bc7e-b094a18d1b82}{60}\" class=\"WACAltTextDescribedBy SCX57151736\"></span><img class=\"WACImage SCX57151736\" src=\"data:image/jpeg;base64,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\" /></p>\n<p>&nbsp;</p>\n<p><strong>Mature pincer grasp</strong></p>\n<p>12 months: the object is secured between the opposed thumb and the tip of the index finger.&nbsp;&nbsp;&nbsp;</p>\n<p><img class=\"WACImage SCX134039010\" src=\"data:image/jpeg;base64,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\" /><img class=\"WACImage SCX134039010\" src=\"data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/2wBDAAMCAgMCAgMDAwMEAwMEBQgFBQQEBQoHBwYIDAoMDAsKCwsNDhIQDQ4RDgsLEBYQERMUFRUVDA8XGBYUGBIUFRT/2wBDAQMEBAUEBQkFBQkUDQsNFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBQUFBT/wAARCAB2AKgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDzTwv8JYNJ82ee51S5j+0Tf6uV7aH/AFrN/wACruIrDT4f9X/5EleuRutUuru/vru/l+0yfaJvJj/gj+f+7V6wun83z5Jf3n/POgDXuvBul6tL+4+1W06f8tLa6fZ/3zXQ6X4XvbSH9/cyyR/35JXrMtb+6h8ry/3kj/cj+/XX2H9o/wDP9+8/65JQBZ0vQUh/eJFLHJ/0zunf/wBmrobWwgu/NgnuZY5Ej/1kd06P/wB8tWZYWt7DL+7li/7af362L/8A0SKKPUovv/8ALDyt/wD49QB5z48tfEvh6X95fXWnabJ+7TWI7p3SPd/eXd8teVeI/C8/2/8A4qWP+1r9I/8AWX0rv5iN/ErfxJXvWqf2RDF59pbRXPnR+X5cm9/k/u7d1cFdWFld2v8AwjV/L5dpNv8A7Gvo/v2Fx/zykb/nk1AHjHgjwva+GdU1e7tP9GjT95DHfSukMaf9M/mrtPCUt74YtbmTQv3n22Tz7v8A0qVPtD/3vvV5z4t+I0/hPWbnTdWiv7a/spPLmgki3p/wGrOveNr7wnJbQeJJf+EdnvI0nt0vZXTz4W/5artoA7zXvGXiWaWPUtW8Pf2lBax/PPZaxLDNHD/uq3zV9pr8G/B/xm8C6WPB8droXjTT/J1m11b586m7JvK3zr+8lim3fN/Gmfkr4Hv/ABH52jf6fY397ps0fzz+bcbJE/66I22vq39hX4lWOuan/Zmm6n9itNJ8m3+wyS/aZpIW+7+8f+Hd8lAHh/jb4/amRrfhTUfBuu+H/Fxu/wCx71ZLpHtbS43fvF3L/wB9K/8AGnlvXD/FDxRq/h6//snRfEN1bwWVuljd6bJE7pcbv4lb+HbX3t+2x8CdAutLl+LKWN/9p0ILd65b6KUSS+tYV/18ilTvaBf/ABwf7CY+M5NY8DeOJrm7tL7xlexw3CTzf2Jpiamkj/eX5ooD8lAF6wtdOisPDXhe01OWS7e4S7u4JLp9+yNN3zV1Ut//AGHNYzzy3XkQ7764/eu/zt92vNbb4ifDaDxRfalaXPi291J7fy5rG5ihxArfL/qXj3Rf9811Nh8WrK0urafSfD0tlPdSJG+ueKNTf93Cv8S/3f8AvmgDcih/sOw+yaLLdfvpPtc0kl07vvb5mXazGvP/AItaPfa1Jb3Vv4g1TTp7O43xQW98yJs/iX73zf8AAqk0HxJ8OfhPL4hjg+I2l6jHqkj3dxffvpr2S4/2v4dv92vGPG3xu0vVptXjk1OWS0kj8u0k022f/vptzffoA3NU8b6pqF/Hd+F7r7TO9x5fl3MrvDGn8TSLVHxlf/EPxNrMsek65YWVpD8n+jXzo8n/AH192vMLH4iaLLfWJnttYuXtY/knjjRPn/3Tla9B8Ea9BrkV1fwfao45v+Wcmx3/APHVoA57/hUHxJ1zzZ5NTlknf/VTx6w7/wDs1Fe4aD/olr5n+rnT/plRQBh3Wqf2hqlzHJ/q0uJv9hPldq6rRovOii/deZv/AO+K5+KwebzZ/K8z/TJo5f8Av63zV0ulxP8AavMkl/4B/BGn96gD0HS9kPlQR/vJ/wDltXVWt/8AZIvLj/ef35P4K4PT7r918n7uD+CP+OR/9qultf30XlyS+ZIn3/8AfoA6+wv/ACbq2kk/1f8ArEqLxRqn9oWsU8fm/wC35dUZb95tP8uOKsi68+GKXzJPL/v0AY91qjzfuJ4vtMH/AE0i+eOsjy4JvNgki/cP9/y9++N/73er11E8MsU8f+o/jq9F4cSG/iu4JfLjeTy6AOa/ab+EF14s8EaZ47tJYvt6W72Oozx/cuE/5ZtXgPxL8B6dDr3hW++039zaa1paSQwalK8zwPH96L52O1K+15bV/wDhHNT0mD95puoR+Xd2P8H/AF1jr42tfBt1D8Qbm783/S/M+yJ9p3u8e37qqtAHZ6D4j8X+E9Gi0LQfEsunaEkflppslrFND/tfLLGa9P8AgP4u8Uah8X/CGhalq+l/YNXkexTyrG3tXj2puXy/JhTdt/uVz8Xw0ntLDTJ7uK/jj1CN/sknlfJf7flbyf8AnrX21+zx+zba/CPR/wC17u3+2+PdQt/Ll1GT5/7MRv8Al0t/7n+0/wDfoA90tVmOhxaVcf8AE2gePy7u7vYv3MiN8rLt/i3VreE/C/h/4f6FZ6F4f06x0XS7OPZBY2UaxJGo9FFfOuqfGjxr4H0e60270O12aZ+7/tLzU2f73+9Xzz488ZfFC88b6RPf+KrqOw1TfGlrYxf6hNm7cv8A7NuoA+wfjZ+zn8N/jDJaanrOm6fY+J7K4jutP8RW8SreJKrfLuZcNNGSQrRPlDz9a+IPjZ+wl8VfF3jbVvFOk+BNLFpdIjvo+na7EPn/AIvs6yqI9v8AvMle9+F9emh8OyaTBc3Uck0kM76rfSu83nRvuVmb+5/sLXpNr8bfEngXXtN0LxZFbar9qtEnhvtJ+dJFb7vmb9jK1AH5V3Hw21axuLiyl8LXOj6jENlxZatH9muYN396M1y2qfBHxRq3+otovLf/AJ9onf8A9BxX6bft0eH7DxV4Z8E+MLG32aouof2dK8f+se1kidijeythq+OftWr6TF5cdzdRx/8APOgD59/4Z48X2kvmSaZdXMiR/wDLtFvrs/Afwq8V+GbCWC70O6jj8zzEklli2f8AjrV7XpfxB1GH9xPLLLH/AM9P4463IvFCXcXmR/6TH/H/APs0AeaapFqOiWH+l20scb/ck+/8/wDwGivUP+Eo0/8A5aReXHRQByGl6M+n/wBpyf8ALP7RN/rP7jO3y0WFr9rv5fL/ANR5fmTR/wAe/wDu/wC0lejXWlpd2GpyeV+8e4fZ/wB91zUWgv8A6NP/AKudJH30ARRS+dF5ccX7xP3cP+/Wvay/ZJbaP91/tyVHpcV1D+8k/wBJk/1cP9+tLRrVPKlnkil+T/gaUAXvNeKKLy5f3lZt/v8Asssf72T/ALZVe8pJv+PiXzJP++HqKK18n7TH/f8A3iUAc9o1152s21pP+7gm/cPH5v8AHXafYPJ8OXPmf69JPLeT/d+61c9/YM82qRSfx/weX/frodU1T+yYvMnl/d3UfzxyRUASRa08Ol+Z/wAtK5H/AIRyy8ZeN9D1aP8A1/mf6d5f3/l/iqt4o8R2Wn6X9rg/eWiff8v7/wA1e3/CX9m690Oxtta8Q6nLc6zNH56aVpvyQ2ife2tJ/wAtXoA+gfDcPgrxVpXhHwxodtFZ6Fp8n2ixS4i2TebD/Auf493zNXTfEX4jWvw/0vyPL+0383FvY/xyf9NW/urXn3w18OaF4m8D339u6b/aMEN5ve1l/vr/ABf7LLVHx/4R0nTdPi1nwxokqbI3+16dbS/wL92Tn+L+9QB4F8ZNe1jxvLF9ruZZLu1kSd47b5Ejf+FvLrr/AIU6za6fFLJdxf2jfTf66fUvnf8A3VrSsPhf/wAJxo1jdzxS/b0t0kTUraXZNH5nzbf9pP8AYqWX4S6j4eiiu45ftMD/APLeKL/Vuv8Az0j/AIf+A0Ae2aD9i1aKL7JFa+f5f/LSL/V7q5TxR8P49J1CMatYxajY3sn/AC8/8tH/ALu6qPg2/wBX0P8Aef2ZLex/xvY/OlexeE/FH9uWv7vzbaR/vwXMXz0AfPf7QHkf2H4f8G2lt5cFlJ/at9HHJv8ALcrthX/2dq+fr/wR53/XN/8Alp/BJX1P8WNHz8RtX8v93G/2Z0/79KtcHdeHPJl/d/x/fg/56UAfPEvgP/tp/wBc/krIl8JT2n7z97/10j+/X01/wjsE0X+q8v8Avx/xx/71Ubrwak3+rioA+c/sE/8ArJ/9Nj/gktotk0f+9/eor3C/8B+d+8j8qOT/AJ6UUAcr4X0b+z9BvpJJftMj3DyP5cu/52f/AGqP7HT7VfRyf6vzP/HK9K16KGGX/jx+zxvv3/c/v/7NcrdaM811fTweb/q/+WlAHK2tgl3rMsfm+Xst/Lq9DYJ5UvkRfu//AGesi61h7S/l8z93H5iR+Z/sfxVZtfEcH2C+nki+5G/7v/YoAteV9kllgj/eSf6x5Ki+SGKXf/r3+5HXNWviN5rqWTyvLjqz9q877dJ/q53/AHaf9M6AOmsLqCG6sYP+WnmfPHXl/wAadens/Ngg/wBZayPG8dRXXjL/AIrK2k/49tkbyP8A8BrD+LWsp4hv5Z7T959qt0n/AHf+z8rUAeYX/i29m/0T7TLHv+55f34/7tfTXgP9sjxL4slsdFu/DVr/AGk+yCa6jvtkMj/d3eX/AA18weKPDjw2Ftdx/vI/45K6b4Z2sF3fxXf2n7NH8kc0kn3I/wDaoA+5PN8c6T9ugtJZbmOaRLu7j0SVHm/3o1f71el/Cr4g+Gv7LufIuZfkkeS7+3b/ADt//TRX+avIYvjJ8OdJv9Mjn+Jeg+ZDZ+Q7/vf3f/kE15j44/aGsfHniiwv/DXh+6j/ALJuPIvtU1KWKG61a33/AHLeEffX+75vz0AfeXg3S7WHRrGOCLy43t/P8v8A557vmo1Sw8nQb7/npD+/T/gPy/8AoNeafD/4jf6VF9r822jm/eeRcxbHj3fd3LXql/rMeoReXHL5m+P5/L/uUAc1oNh5MVtPBLLFI/8A6BXoOjXV1D/rJfMjrjIt+nyxfvf3f8ddLpcv7vzI5aAOH+Klih8YyyPJGPOt4a5Ga1T/AJ6+ZVzxpdajp/xZ8Qx3c10kF7pljd6dB5LvDsjOyba33fN3feT+5WdNdf8ALSOL/tnQBWlsP+Wkcsscn/Pf5/8Ax6ovsv8Ayzk/dyf88/N/9BqzLfz/APLO58vzP+mVVrqXzov3nmx/3JP+ef8Au0AH9l/9daKItUeHyo7v/WP9yf8Agk/+JeigDlZbDzvtN3J5scj3D+TH/sVFoP8Ay1jki/7af7FdVLapNFLHH+7jTfsrjIrr7JqlzJQB5F8RrBIdUljji8uP7R59ee/29/pVzaT/AMf/ACwj+/XuHxBtYLTR5bv/AFcj/wDobV4D4N0Z9c166/dfvEk+eT/boAl/tSfTrWPzP3caf8s//Zd1XrrXkmtY/I/gj+f/AHK73xb8L3u9Li8v/nn5b/79ee/DS1gmurnTbv8Ad3dlJ5b/AO5QBzWqSvqEsvly/afJj+SP+P5v7teff8JRe6HdReX/AKTPa7/3EnyeYn8S19UeI/gj9r0/+0tNl+//AMtIv+WdeV+KPhzP50X2vSJY5/8AVpPbfvoZP/ZloA4u18UaXqEXmaTfRW0b/wCu0O+/5Z/7rfxV6p8KvhLa+Jrrfd3N/oum3sfmeZpuxP8AvlnauV8Ofsv2WoSxX9/rl1pUCfvPsMVijvJ/203fLX0t4S0vS9JsLawsIpY4IY/3Mf8AzzoA898R/soWUN1FJ4e8e3Uck0nl+RrdrFvj/wC20Od3/fNWrD9mnxXNa/ZLvxD4Dlj/ANWl1JFcPc/99LGle16hF9k0uKSS28uNLhJK6WWWCHzfLsYpI6APmXRvgP8AF34e+I/M0LU9B8V2k8nmfbr7XZf9E2/eVvtC+Z83/A69ii+KGo/D3XpdC8Q+VHrSWdtfTSaTL9qtvs8jyLGyttDfeik/hrs/9Fm/5hksf/bKvBtQv9Om/am8S2FpY3VlI+h20dxdXMv/AB8XEb74/LX+H5fMoA9s0H4yWV3+7n1OKTf/AM9JUT/0KvXfh94jg8Q+VBYS/adn354/nSOvFNL8JWWoS+ZPY6XcyfxyXNr/APE1794DiS00uKCCWKOBP4LGLYn/AH1QB3PizwZYeMPD506ceUU+e3n/AI4JecNXyhrGrXOl6lcWVzH5F7ZyeRcLF/Ay19iaZdJND/zzrxL9oT4fqbtPFFrHkPsh1Bf937sn/stAHiUvjJP+Wd9+8T/lnVX/AITJP+fn/tnJUd/oM/8Ayziikj/8frM/sd/+WkVAGv8A8Jak0UqfaZfLf/ln5T7KKzZdLeb/AFn/AH78qigDs9L1lJvN/e/8tH/d/wDA65XxRs0/VIpP+WF1H5dVvtU+nyS+X+8g8x//AEOqOs6zBq2ly2k/7uT/AFiSf883oAzPHkUmrWFtYf6yOGPzHjj+/I/8NWfgt8NHtPKu7+L94/7x46PC9/aw/vL/AP4+P45JK9CsPFtlD+7joA0tZ0GCa68uP/lnXzx8RvCX/CG/Ea21qCL/AEC9j8i4/wB/+Fq9+/4Si1mrkPHn2LxDYbJP9Z/B/v0AbHw01nybDy5PKuY/460vFFrok0Us8ccVtJ5fzyeUjpJ/vLXlegxajDL5dhbfvP45PuJ/31V61+1eINU+wWFza3t3D/rZJJf9Gt//AI69AG54c0GfXLW5tIIvtNha/P8Au4tifNWxcw6F4E0Iaz4n1ew8O6UZPL+3alcpCm/+7z9+vjL9sLxRr3gP4q+ELHwpqWoWXiD7G7rqtjdSw3O9n/h2MPl/2K8i13/hOPjZ8SpbDxJ441TXb7SbN51vvEcr/JtT7sMLNtWgD9QbDXtB8WeCL7UvD2uWHiPTU+5daTdJMkbr/C22vRtLtYNWtYp/KijkkjT/AFn/AC0+SvzL8G6z4o/ZV8N+KtasL6wvZNX0uGObTvKS5/fN/wAt5I3+7/vrXPeF/wBsz416TqkV3d+OLrWrHy/n02SXyU2f3Y/Kx5X/AAGgD9R7/S3tP9XLFJ/1zr5O/bCtYfCfxQ+GnjuCK/0m7SR477WJP+QfIi/KsTfxebtavOfBv/BQT4paTJLP4i0jS/F/hfzPmkvbXybyBf7kdxFtWVl/2q7T9qfUvDHxx+EPhHx74V8XfbLVLx7VNGli8lI5W/1n2hU+ZZVoA+lPCWswaha213H/AKuaNJE/4FXr3hHVI/K8vzYv9ivk34VXWqeGdB0jTdai0vz/ALOkkMmkyu9tIn/Avmr3DwvrPkyx+X+8oA+g9Gv/APprWvf2trrljc2M8fmQTR7Hjrg9B1RLuKKTza7i1uvO8qgD5l1Twu+h39zYTxeW8Mnl+Z/sfwtWZLoL/wCs/wCWf/A3r2H4saPH/wAJFY3UdzLHJcxuPLj2fvNtedXVgnm+ZHLdSf8ATSOV6AOa/wCEcSaL/VeZIlFdD9lgm/1n2rzP+vp6KAOQv/AaXf2mewuZbZ3kf9399Pv/AN2vIfFuvT+Gb/7Jq2keZ/cnji/1n/xNe66Df+dF5kcv9/8A7aV1Uvg3SPFkXl39tF57/foA+Nr/AOI3hqG6igu4r+ykf7nl/PWnpeqPqH7zRdM1m9j/AOnmLYlfUf8AwoLwjpMUc/2aKSSGTzIf3X+rrMli0vT7ry4/+/ccX8FAHhdhF4lu/wB3BpEsX/XSteL4feJdQi/f3MWnSf8AfdfWXhzwlp13pcU/leZvj8zzK5D4l6W+kxfaNNii+SPzHjoA8KsP2d/GXiGWKO78VXVzYP8AfgsYvJ/9Br1nQfhLa/DfQZYI/K8x/v8Al/8AoVbnhfxb9ksP3ktcJ8dfj/ofww8H3PiDX72OCGAFLe0En767uAMiONaAPzs/bl8d/wBn/tFSpYx21xNp+mJaP9p+dE3fNXz1LawQy2P2SKX54/MuZJPub/8AZq3rXiPV/G3jK+8X30cU2o6nePI6Sf32+6tWJdGvdP17/S/Ktp4f3jwffTf/ALOPloAl1TxJqmr/AGJNT+1XMFn8j3Xz/aZE/uySPmrOn3WnebL599Lp2kv9z/ls+/8AhXtuqz4NsH8eeMv7Nv8AV5baR/36RyWMsyXEy/wtHCpbZXo+vWvhTxt8X9M0LwZoejRWiRpayyR33kpd3H/LRlkl+Xf/AMBoA85h8RxzeEf+Eenjv5NW+0fa/tUl9/o1pD/dW35+arNrK/hnWLGe/wDt9lHdbJJp9Nuv30kP+yu7bvr0/wDaWi0H4WxWPgzQvCH/AAh++Pz76e52TPd/9tPMdv8A0CvAZZbX/hHbmfypft//AI5GlAH3x+yjs8WfDvWNd02+vtRkfVHeKfVrmWabYqfdZnY19F+HNUSbyvMi8uf+OOSvkv8A4J7+LP7P0HXPBt9JHFdW2zUrdPM3iS3k+83y19jy2EE37zyvnoA9Z8Eap50XlyS/vK9P0u6rwrwbKmn3X/POOvVdGv8AzvKkj/1dAFj4l+G08WeGPIg/dX9rJ59jdSfwTL/8VXmujSweINL8/wAry7vzPIuIJJfnt5lrvfiX4j/sP4fanf8Am+XImyNP99n2/wB015pqn/Epv/7d8r9w+yPU4/K+fZ/z12/7NAEt1pcEPm/vZfM/jkji3+XRWvLsmh/0S5/d/wCs8yP+5RQB8Tfsv/FLVNU+HNjHqW68nt7y4sPtLTfMyLIwQYxjAFfS+h+IrxH3KFDf75/woooA15vEdxLb7ZdzL6CQ1gaXeajo/iS51OxjtpXlXbLb3DkIV9MhSaKKANXSvjs/hWze0n0ndEn3DFOGI/76UVyPxu+Jmsw6bBdTWUDz3S7YoI7t0i2+jnZk0UUAfCviL9vXxP8AaL/StG8P2dpMvSe4uWkQf9s9mP1rjf2h/B/iXxl4U8M+MNe1uO8vZLdt9uC2yPL87Djj8qKKAPN7H4bX11byuxtYlt/4VmZt35x1cfwRfPpsV2ssLPbzbfJeVtrL6Z25oooATwfDrnhHXL7U7AwRXwtpbdbiO8kR4QU5KEJxXPt4b1Nrqz3NbnbF56/vm+9jO77n3s0UUAWz4O1bxhdXUn20yS2qG4luL67eaSXHQZKUmo+G766h023W2sbfP+taOd/33+98lFFAG34FvfEvwv8AHGn6xoFxbwX4kEkkUkzNFKh6xN8mdtfpV8HPiYPif4PsNbhsn0/7TH89s82/Y/oHABK/UUUUAep6ZJcLL+88uT8DXpvhy9aeGL5Qv0oooA8S+OHxsktbHW9Wn0MalofhW+itLDS5L4wpf37pxNdARtiNP4UBauq0uG5h0yxEwhnlljXzQxYozt98c/wmiigCLw/qFxodxdaIEjktbVWmtHDEMkZ6xng0UUUAf//Z\" /></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4329",
      "difficulty": "medium"
    },
    {
      "text": "Which pattern of inheritance does the pedigree chart denote?",
      "choices": [
        {
          "id": 1,
          "text": "Autosomal dominant disorder"
        },
        {
          "id": 2,
          "text": "X - linked dominant disorder"
        },
        {
          "id": 3,
          "text": "Autosomal recessive disorder"
        },
        {
          "id": 4,
          "text": "X -  linked recessive disorder"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above pattern of pedigree chart denotes a pattern of <strong>X- linked dominant inheritance.</strong></p>\n<p>Points in favour of X linked dominant inheritance in the given chart:</p>\n<ul>\n<li>Females affected twice as often as males.</li>\n<li>Affected female shows 50% probability of transmitting the disease to her son or daughter.</li>\n<li>Affected male transmits the disease to all his daughters and none of his sons.</li>\n</ul><hr><h3>Related Pearl: Pedigree chart for different inheritance patterns</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b04518e36bdd471daf76691dafd74139x1280x2969.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/195c2ef3907e4d8eac2c909799cbef3ex1280x2742.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://daily-rounds-staging.s3.amazonaws.com/uploads/b1cd5073d2134506badfbe5b5a70a925.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4330",
      "difficulty": "medium"
    },
    {
      "text": "A baby assessed at 5 minutes after birth, had blue extremities and irregular gasping respiration. Heart rate was 40/min and there was  grimace with some flexion of extremities. APGAR score for this newborn is _______",
      "choices": [
        {
          "id": 1,
          "text": "5"
        },
        {
          "id": 2,
          "text": "4"
        },
        {
          "id": 3,
          "text": "2"
        },
        {
          "id": 4,
          "text": "1"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>APGAR score in this baby is 5.</p>\n<p>In this baby</p>\n<ul>\n<li>Colour: Blue extremities -&nbsp;score 1</li>\n<li>HR &lt; 100/min - score 1</li>\n<li>Grimace - score 1</li>\n<li>Some flexion of extremities -&nbsp;score 1</li>\n<li>Irregular respiration -&nbsp;score 1</li>\n</ul>\n<p>Thus total score is 5.</p>\n<p>At 1 minute and 5 minutes after birth of the infant, the 5 objective signs listed here are evaluated and each is given a score of 0, 1, or 2.</p>\n<p>A total score of 10 indicates an infant in the best possible condition. An infant with a <strong>score of 0-3 requires immediate resuscitation</strong>.</p><hr><h3>Related Pearl: APGAR score</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b8de3fc0585847cab3e28e1f55d906e2x1279x1330.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4332",
      "difficulty": "medium"
    },
    {
      "text": "A 7-year-old child is brought to the pediatric OPD by his parents with complaints of excessive sleepiness, and poor scholastic performance. On examination, the child has pallor involving the tongue, conjunctiva, and nail beds. A flow murmur is heard upon auscultation. Which of the following is the most likely cause of the underlying disease?",
      "choices": [
        {
          "id": 1,
          "text": "Congenital hypoplastic anemia"
        },
        {
          "id": 2,
          "text": "Acquired hypoproliferative anemia"
        },
        {
          "id": 3,
          "text": "Congenital hemoglobinopathies"
        },
        {
          "id": 4,
          "text": "Hyperproliferative anemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical signs and symptoms are suggestive of <strong>anemia</strong>. <strong>Acquired hypoproliferative anemia,</strong>&nbsp;is&nbsp;the <strong>most common</strong> <strong>cause</strong> of anemia in children among the given options.</p>\n<p><strong>Iron-deficiency anemia</strong> (which is classified as an acquired hypoproliferative anemia) is the <strong>most common cause </strong>of anemia in<strong> children and adults</strong> <strong>worldwide</strong>. Iron deficiency is also the <strong>most common nutrient deficiency worldwide.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3058",
      "difficulty": "medium"
    },
    {
      "text": "All of the following statements belong to the 10 steps of successful breastfeeding recommended by the Baby Friendly Hospital Initiative (BHFI), except _____.",
      "choices": [
        {
          "id": 1,
          "text": "Have a written breastfeeding policy"
        },
        {
          "id": 2,
          "text": "Help mothers initiate breastfeeding within 4 hours of birth"
        },
        {
          "id": 3,
          "text": "Counselling on formula milk "
        },
        {
          "id": 4,
          "text": "Practice rooming in 24 hours a day"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>BHFI recommends breastfeeding <strong>as soon as possible</strong>after birth.</p>\n<p><strong>BFHI</strong> is sponsored by the WHO and the United Nations Childrens Fund to <strong>promote breastfeeding.</strong></p><hr><h3>Related Pearl: Baby-friendly hospital initiative (revised 2018)</h3><h2 class=\"module_title\"><span>Ten steps to successful breastfeeding (Revised 2018)</span></h2>\n<table>\n<tbody>\n<tr>\n<td>\n<h2 class=\"module_title\"><span>Critical management procedures</span></h2>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>1&nbsp; a.</strong>&nbsp;Comply fully with the&nbsp;<strong>International Code of Marketing of Breast-milk Substitutes</strong>&nbsp;and relevant World Health Assembly resolutions.</p>\n<p><strong>&nbsp; &nbsp; b.</strong>&nbsp;Have a <strong>written infant feeding policy</strong> that is routinely communicated to staff and parents.</p>\n<p><strong>&nbsp; &nbsp; c.</strong>&nbsp;Establish ongoing monitoring and data-management systems.</p>\n<p><strong>2.</strong>&nbsp;Ensure that <strong>staff has sufficient knowledge, competence, and skills</strong> to support breastfeeding.</p>\n<table>\n<tbody>\n<tr>\n<td>\n<h2 class=\"module_title\"><span>Key clinical practices</span></h2>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>3.</strong>&nbsp;<strong>Discuss</strong> the importance and management of breastfeeding with pregnant women and their families.</p>\n<p><strong>4.</strong>&nbsp;Facilitate immediate and uninterrupted <strong>skin-to-skin contact</strong> and support mothers to initiate <strong>breastfeeding as soon as possible</strong> after birth.</p>\n<p><strong>5.</strong>&nbsp;Support mothers to <strong>initiate and maintain breastfeeding</strong> and manage common difficulties.</p>\n<p><strong>6.&nbsp;Do not provide</strong> breastfed newborns <strong>any food or fluids other than breast milk</strong>, unless medically indicated.</p>\n<p><strong>7.</strong>&nbsp;Enable mothers and their infants to remain together and to practice <strong>rooming-in</strong> 24 hours a day.</p>\n<p><strong>8.</strong>&nbsp;Support mothers to <strong>recognize and respond to their infants&rsquo; cues</strong> for feeding.</p>\n<p><strong>9.</strong>&nbsp;<strong>Counsel mothers</strong> on the use and risks of <strong>feeding bottles, teats, and pacifiers</strong>.</p>\n<p><strong>10.</strong>&nbsp;<strong>Coordinate discharge</strong> so that parents and their infants have timely access to ongoing support and care.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4333",
      "difficulty": "medium"
    },
    {
      "text": "A concerned mother brought her daughter to the clinic for evaluation of symptoms that have worsened in the last few weeks. The daughter frequently wakes up at night with severe headaches and vomiting. She has also been having some difficulty walking. On examination, ataxia and multiple cranial nerve palsies are noted.  Imaging is suggestive of a brainstem tumor. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Pontine glioma"
        },
        {
          "id": 2,
          "text": "Medulloblastoma"
        },
        {
          "id": 3,
          "text": "Ependymoma"
        },
        {
          "id": 4,
          "text": "Acoustic neuroma"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The MRI given shows a<strong> diffuse, infiltrating pontine lesion</strong>. Multiple cranial nerve dysfunctions, cerebellar signs, motor weakness, and features of raised intracranial pressure (ICP) are all strongly suggestive of a <strong>pontine glioma.</strong></p>\n<p>These are not amenable for surgical resection. The standard approach is&nbsp;<strong>radiation therapy</strong>. The prognosis is very poor.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0a15d91c0b284e22aa2a45d8927c8fdd.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7782",
      "difficulty": "medium"
    },
    {
      "text": "True regarding vitamin C deficiency is:\na) Poor mineralisation of bone\nb) Angular and sharp costochondral junction\nc) Nodularity at costochondral junction\nd)Lucent metaphyseal band underlying the calcified cartilage at metaphysis",
      "choices": [
        {
          "id": 1,
          "text": "Only A"
        },
        {
          "id": 2,
          "text": "A, B, C & D"
        },
        {
          "id": 3,
          "text": "B & D"
        },
        {
          "id": 4,
          "text": "D & C"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Angular and sharp costochondral junction i.e <strong>scorbutic rosary</strong> and lucent metaphyseal band underlying the calcified cartilage&nbsp; i.e. <strong>trummerfeld zone</strong> are seen in vitamin C deficiency.</p>\n<p><strong>Radiological signs in Vitamin C deficiency(scurvy):</strong></p>\n<ul>\n<li><strong>White line of Frankel</strong>: calcified cartilage at metaphysis</li>\n<li><strong>Trummerfeld zone</strong>: lucent metaphyseal band underlying Frankel line</li>\n<li><strong>Pelkan spur</strong>: lateral prolongation of white line which is present at cortical ends</li>\n<li><strong>Wimberger ring sign</strong>: circular, opaque radiologic shadow surrounding epiphyseal centres of ossification</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/19f2510d30254404850208d63d438268x725x589.PNG\" alt=\"Explanation Image\"><p>Poor mineralisation of bone and nodularity at costochondral junction are features of vitamin D deficiency.</p><hr><h3>Related Pearl: Important differences between vitamin D and vitamin C deficiencies</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td>\n<div><strong>Vitamin D &nbsp; &nbsp; deficiency&nbsp;&nbsp;<br /></strong></div>\n</td>\n<td>\n<div><strong>Vitamin C &nbsp; &nbsp; deficiency<br /></strong></div>\n</td>\n</tr>\n<tr>\n<td><strong>Pathology</strong></td>\n<td>Poor mineralization of bone</td>\n<td>Poor osteoid&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; formation</td>\n</tr>\n<tr>\n<td><strong>Clinical features</strong></td>\n<td>\n<p>No/less irritability</p>\n<p>Rachitic rosary (nodularity at the costochondral junction)</p>\n</td>\n<td>\n<p>Irritability is predominant</p>\n<p>Scorbutic rosary (angular &amp; sharp costochondral junction)</p>\n</td>\n</tr>\n<tr>\n<td><strong>Radiological features</strong></td>\n<td>\n<p>Cupping&nbsp;</p>\n<p>Fraying</p>\n<p>Splaying</p>\n</td>\n<td>\n<p>White line of Frankel</p>\n<p>Pelkan spur</p>\n<p>Wimberger ring sign</p>\n<p>Subperiosteal hemorrhage</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note:</strong> Irritability in scurvy is due to hampered neurotransmitter production (conversion of dopamine to norepinephrine and tryptophan to serotonin requires vitamin C).</p><hr><h3>Related Pearl: Synthesis of collagen and its disorders</h3><table>\n<tbody>\n<tr>\n<td>1. Collagen backbone</td>\n<td>Preprocollagen - Glycin-proline-lysine</td>\n</tr>\n<tr>\n<td>2. Hydroxylation</td>\n<td>\n<p>Of proline and lysine in the presence of Vit C.</p>\n<p>Deficiency of Vit C causes <strong>Scurvy.</strong></p>\n</td>\n</tr>\n<tr>\n<td>3. Glycosylation</td>\n<td>Formation of procollagen and resulting triple helix</td>\n</tr>\n<tr>\n<td>4. Cleavage of terminals of procollagen</td>\n<td>Resulting in the formation of tropocollagen</td>\n</tr>\n<tr>\n<td>5. Cross-linking by lysyl oxidase (copper-containing enzyme)</td>\n<td>\n<p>Formation of mature collagen.</p>\n<p>Defect causes <strong>Menkes disease</strong> and <strong>Ehlers-Danlos syndrome</strong>)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4334",
      "difficulty": "medium"
    },
    {
      "text": "Ponderal index is ____.",
      "choices": [
        {
          "id": 1,
          "text": "Square root of fetal weight (cm)*100/weight (g)"
        },
        {
          "id": 2,
          "text": "Fetal weight (g)*100/cube of fetal length (cm)"
        },
        {
          "id": 3,
          "text": "Fetal weight (kg)*100/cube of fetal length (cm)"
        },
        {
          "id": 4,
          "text": "Square root of fetal length (cm)*100/fetal weight (kg)"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Ponderal index = Fetal weight in grams X 100/(fetal length in centimeters)<sup>3</sup></strong>(Option B)</p>\n<p>A ponderal index (PI) is one of the anthropometric methods used to diagnose impaired fetal growth. The percentiles allow the discrimination between symmetric and asymmetric growth restriction in preterm and term infants. PI below 10<sup>th</sup> centiles is taken as fetal growth restriction.</p><hr><h3>Related Pearl: Indicators for Body fat</h3><p><strong>The indicators for body fat are:</strong></p>\n<p><strong>Body weight</strong>: +3SD (standard deviations) from the median weight for height as a cut-off point for obesity. For adults, some people calculate various other indicators such as:</p>\n<ul>\n<li><strong>Body mass index (Quetelet's index)</strong>: Weight (kg) / Square of height in metres</li>\n<li><strong>Ponderal index</strong>: Weight (kg)/Height^3 (m)</li>\n<li>Corpulence index: Actual weight /desirable weight.(Should not exceed 1.2)</li>\n</ul>\n<p><strong>Broca's index</strong>= Height (cm) - 100 .</p>\n<p><strong>Lorentz's formula</strong><br />Ht (cm) - 100 - [ (Ht (cm) - 150) / 2 for women or 4 for men ]</p>\n<p><strong>Skinfold thickness:</strong>Four sites mid-triceps, biceps, subscapular and suprailiac regions. The sum of the measurements should be less than 40 mm in boys and 50 mm in girls.</p>\n<p><strong>Waist circumference and waist-hip ratio</strong>: At the mid point between the lower border of the rib cage and the iliac crest. There is an increased risk of metabolic complications for men with a waist circumference~ 102 cm, and women with a waist circumference~ 88 cm. A high WHR (&gt; 1.0 in men and&gt; 0.85 in women) indicates abdominal fat accumulation.</p>\n<p><strong>Total body water</strong></p>\n<p><strong>Total body potassium</strong></p>\n<p><strong>Body density</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4335",
      "difficulty": "easy"
    },
    {
      "text": "Match the following primitive reflexes with its age of disappearance:<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>(A) Moro reflex</td>\n<td>(i) 2-3 months postnatal</td>\n</tr>\n<tr>\n<td>(B) Parachute reflex</td>\n<td>(ii) Less prominent after 1 month</td>\n</tr>\n<tr>\n<td>(C) Rooting</td>\n<td>(iii) 5-6 months postnatal</td>\n</tr>\n<tr>\n<td>(D) Tonic neck reflex</td>\n<td>(iv) 3-4 months</td>\n</tr>\n<tr>\n<td>(E) Palmar grasp</td>\n<td>(v) Throughout life</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "A- iv   B- v   C- ii  D- iii  E-i"
        },
        {
          "id": 2,
          "text": "A-iii  B- v   C- ii  D- iv  E- i"
        },
        {
          "id": 3,
          "text": "A- iii  B-v    C-i    D- iv  E-ii"
        },
        {
          "id": 4,
          "text": "A- iv B v   C-i    D- iii  E-ii"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<ul>\n<li>Moro reflex disappears by 5-6 months of age.</li>\n<li>Parachute remains throughout life.</li>\n<li>Rooting is less prominent after 1 month of age.</li>\n<li>Tonic neck reflex disappears by 4 months of age.</li>\n<li>Palmar grasp disappears by 2-3 months of age.</li>\n</ul><p>Note: According to Ghai Essential Paediatrics, 9th edition, tonic neck reflex disappears by 4 months of age. According to Nelson Paediatrics, 21st edition,&nbsp;tonic neck reflex disappears by 6 months of age. Hence, the answer depends on the reference chosen by the examiner.</p><hr><h3>Related Pearl: Timeline for primitive reflexes</h3><table><caption></caption>\n<tbody>\n<tr>\n<td>\n<div><strong>Reflex</strong></div>\n</td>\n<td>\n<div><strong>Onset</strong></div>\n</td>\n<td>\n<div><strong>Fully developed</strong></div>\n</td>\n<td>\n<div><strong>Duration</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Palmar grasp </strong></div>\n</td>\n<td>\n<div>28 weeks of gestation</div>\n</td>\n<td>\n<div>32 weeks of gestation</div>\n</td>\n<td>\n<div>2-3 months postnatal</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Rooting </strong></div>\n</td>\n<td>\n<div>32 weeks of gestation</div>\n</td>\n<td>\n<div>36 weeks of gestation</div>\n</td>\n<td>\n<div>Less prominent after 1 month postnatal</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Moro </strong></div>\n</td>\n<td>\n<div>28-32 weeks of gestation</div>\n</td>\n<td>\n<div>37 weeks of gestation</div>\n</td>\n<td>\n<div>5-6 months postnatal</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Tonic neck </strong></div>\n</td>\n<td>\n<div>35 weeks of gestation</div>\n</td>\n<td>\n<div>1 month postnatal</div>\n</td>\n<td>\n<div>3-4 months postnatal</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Parachute </strong></div>\n</td>\n<td>\n<div>7-8 months postnatal</div>\n</td>\n<td>\n<div>10-11 months postnatal</div>\n</td>\n<td>\n<div>Remains throughout life</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p></p>\n<p><span>According to Ghai Essential Paediatrics, 9th edition, tonic neck reflex disappears by 4 months of age. According to Nelson Paediatrics, 21st edition, tonic neck reflex disappears by 6 months of age. Hence, the answer depends on the reference chosen by the examiner.</span></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4338",
      "difficulty": "medium"
    },
    {
      "text": "On your pediatrics rotation, you notice a 2-day-old baby with the rash shown in the image below. Which among the following is the most likely cause for this baby's rash?",
      "choices": [
        {
          "id": 1,
          "text": "Rubella"
        },
        {
          "id": 2,
          "text": "Measles"
        },
        {
          "id": 3,
          "text": "Erythema infectiosum"
        },
        {
          "id": 4,
          "text": "Varicella"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The image shows&nbsp;<strong>purple papulonodular lesions,&nbsp;</strong>which are suggestive of&nbsp;<strong>blueberry muffin rash. </strong>It<strong>&nbsp;</strong>is seen in <strong>congenital&nbsp;rubella.</strong></p>\n<p>Blueberry muffin rash&nbsp;represents&nbsp;<strong>dermal erythropoiesis</strong>. In addition to congenital rubella, it can be seen in:&nbsp;</p>\n<ul>\n<li>Congenital viral infections such as cytomegalovirus and parvovirus</li>\n<li>Neoplasms such as neuroblastoma and acute myeloid leukemia</li>\n<li>Rh hemolytic disease</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/40ebdc760f064918adaa696eb811a7e5.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5900",
      "difficulty": "medium"
    },
    {
      "text": "All of the following are screening tests for development surveillance except _______",
      "choices": [
        {
          "id": 1,
          "text": "Denver II"
        },
        {
          "id": 2,
          "text": "Phataks baroda test"
        },
        {
          "id": 3,
          "text": "Bayley  II"
        },
        {
          "id": 4,
          "text": "Gesel figures and block skill"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Bayley II</strong> is a <strong>definitive test</strong> of developmental quotient. Denver II,&nbsp;Phatak&rsquo;s baroda test and&nbsp;Gesel figures and block skill are developmental <strong>screening tests.</strong></p>\n<p>&nbsp;</p>\n<table><caption><strong>Tests for developmental quotient</strong></caption>\n<tbody>\n<tr>\n<td><strong>Definitive Tests</strong></td>\n<td><strong>Screening tests</strong></td>\n</tr>\n<tr>\n<td>\n<ul>\n<li>Bayley scales of infant and toddler development <strong>(Bayley-II)</strong></li>\n<li>Stanford-Binet Intelligence Scale</li>\n<li>Wechsler Intelligence Scale</li>\n<li>Developmental Activities Screening Inventory (DASI-II)</li>\n<li>Vineland adaptive behaviour scale II</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Denver-II developmental screening test</li>\n<li>Phatak&rsquo;s Baroda screening test</li>\n<li>Trivandrum development screening chart</li>\n<li>CAT / CLAMS</li>\n<li>Goodenough Harris draw-a-man test</li>\n<li>Gesel figures and block skills</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4339",
      "difficulty": "hard"
    },
    {
      "text": "A 4-month-old infant who was started on a high-protein diet after weaning from breastfeeding developed severe metabolic acidosis, ketosis, failure to thrive, mild hepatomegaly, and an unusual swimming pool odor. A history of similar illness was noticed in his siblings and his father. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Maple syrup urine disease"
        },
        {
          "id": 2,
          "text": "Isovaleric acidemia"
        },
        {
          "id": 3,
          "text": "Hawkinsinuria"
        },
        {
          "id": 4,
          "text": "Phenylketonuria"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical vignette and the characteristic<strong>&nbsp;swimming pool odor</strong>&nbsp;describe&nbsp;<strong>Hawkinsinuria</strong>.</p>\n<p><strong>Hawkinsinuria&nbsp;</strong><strong>is an autosomal-dominant</strong>&nbsp;condition&nbsp;caused by <strong>mutations in the gene for 4-HPPD</strong>.</p>\n<p>In infants, this disease&nbsp;causes severe metabolic acidosis, ketosis, failure to thrive, mild hepatomegaly, and swimming pool odor. Mental development is usually normal. Affected individuals excrete <strong>hawkinsin</strong> (4-hydroxyphenylpyruvic acid), and its metabolites.</p>\n<p><strong>Treatment </strong>consists of a <strong>low-protein diet during infancy</strong>. Breastfeeding is encouraged. A trial with large doses of vitamin C (up to 1,000 mg/24 hour) is also recommended.</p><hr><h3>Related Pearl: Inborn Errors of Amino Acid Metabolism and Their Associated Urine Odor</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Inborn Error of Metabolism</strong></p>\n</td>\n<td>\n<p><strong>Urine Odor</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease</p>\n</td>\n<td>\n<p>Maple syrup</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hawkinsinuria</p>\n</td>\n<td>\n<p>Swimming pool</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3-Hydroxy-3-methylglutaric aciduria</p>\n</td>\n<td>\n<p>Cat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n<p>Glutaric acidemia (type II)</p>\n</td>\n<td>\n<p>Sweaty feet</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypermethioninemia</p>\n<p>Tyrosinemia</p>\n</td>\n<td>\n<p>Boiled cabbage</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Multiple carboxylase deficiency</p>\n</td>\n<td>\n<p>Tomcat urine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Mousy</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Trimethylaminuria</p>\n</td>\n<td>\n<p>Rotting fish</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Oasthouse syndrome</p>\n</td>\n<td>\n<p>Dried malt/hops</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA7648",
      "difficulty": "medium"
    },
    {
      "text": "2-year-old Neha has been having fever since yesterday and is refusing food. Parents became alarmed when she developed an abnormal barking cough today morning and have brought her to the casualty. On examination, the child looked exhausted and had visible chest retractions and stridor. The temperature was 39.6 degrees and SpO2 was 93% on room air. Chest X-ray reveals a 'steeple' sign. What is the treatment of choice in this child?",
      "choices": [
        {
          "id": 1,
          "text": "Racemic epinephrine nebulization"
        },
        {
          "id": 2,
          "text": "Humidified oxygen and salbutamol nebulization"
        },
        {
          "id": 3,
          "text": "Send a throat swab and start IV antibiotics"
        },
        {
          "id": 4,
          "text": "High dose dexamethasone injection"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Fever, barking cough, inspiratory stridor and a steeple sign on chest radiograph are suggestive of <strong>acute laryngotracheobronchitis</strong> (croup). The treatment of choice in this child is <strong>nebulization&nbsp;with racemic epinephrine.&nbsp;</strong></p>\n<p>Epinephrine <strong>acts rapidly</strong> and provides immediate relief. It <strong>constricts pre-capillary arterioles</strong> in the upper airway mucosa and decreases capillary hydrostatic pressure. This increases fluid resorption and <strong>reduces airway edema.</strong></p>\n<p><strong>Westley Croup Severity Score:</strong>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>&nbsp;0</strong></td>\n<td><strong>1</strong></td>\n<td><strong>2</strong></td>\n<td><strong>3</strong></td>\n<td><strong>4</strong></td>\n<td><strong>5</strong></td>\n</tr>\n<tr>\n<td><strong>Stridor</strong></td>\n<td>None</td>\n<td>With agitation</td>\n<td><strong>At rest</strong></td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Air Entry</strong></td>\n<td>Normal</td>\n<td>Decreased</td>\n<td>Markedly decreased</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Retractions</strong></td>\n<td>None</td>\n<td><strong>Mild</strong></td>\n<td>Moderate</td>\n<td>Severe</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Cyanosis</strong></td>\n<td>None</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>With agitation</td>\n<td>At Rest</td>\n</tr>\n<tr>\n<td><strong>Level of Consciousness</strong></td>\n<td><strong>Normal,</strong> including sleep</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n<td>Disoriented</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Overall score and severity</strong></p>\n<ul>\n<li>0 to 2- mild</li>\n<li><strong>3 to 7- moderate</strong></li>\n<li>8 to 11- severe</li>\n<li>12 to 17- impending respiratory failure</li>\n</ul>\n<p><strong>Treatment of moderate to severe croup :</strong></p>\n<ul>\n<li>Racemic <strong>epinephrine</strong> nebulization</li>\n<li><strong>Dexamethasone </strong>is indicated in all grades of croup and is given<strong>&nbsp;</strong>by the least invasive route <strong>(Oral</strong>&gt;IM&gt;IV<strong>)</strong></li>\n<li><strong>Oxygen</strong> should be administered to children who are hypoxemic (SpO2 &lt;92 %)</li>\n<li>Antibiotics are <strong>not indicated</strong> in croup</li>\n</ul><hr><h3>Related Pearl: Acute Stridor/ Noisy breathing</h3><p>Stridor indicates an upper airway problem. Look for a history of foreign body aspiration and signs of toxicity.</p>\n<p>Important differentials:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Condition</strong></td>\n<td><strong>&nbsp;Findings</strong></td>\n</tr>\n<tr>\n<td><strong>Croup</strong></td>\n<td>\n<p>Non-toxic, viral prodrome, barking cough</p>\n<p>X-ray neck shows <strong>steeple sign</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Epiglottitis</strong></td>\n<td>\n<p>Toxic child, drooling saliva</p>\n<p>Lateral X-ray neck shows <strong>thumb sign</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Diphtheria</strong></td>\n<td>Unimmunized child, cervical lymph nodes (bull neck), dirty grey/ white membrane</td>\n</tr>\n<tr>\n<td><strong>Foreign body aspiration</strong></td>\n<td>Choking, decreased air entry, unilateral hyperinflation</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9533",
      "difficulty": "medium"
    },
    {
      "text": "A fetus with intrauterine growth restriction was born prematurely with jaundice, hepatosplenomegaly, microcephaly, and diffuse petechiae at birth. A brain CT was done which revealed periventricular calcifications. What is the best method for the diagnosis of the etiological agent?",
      "choices": [
        {
          "id": 1,
          "text": "Urine examination"
        },
        {
          "id": 2,
          "text": "Liver biopsy"
        },
        {
          "id": 3,
          "text": "Blood examinaton"
        },
        {
          "id": 4,
          "text": "CSF examination"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Periventricular</strong> <strong>calcifications</strong>&nbsp;and&nbsp;<strong>microcephaly</strong> in a baby with suspected congenital infection point toward <strong>cytomegalovirus</strong> (CMV). The best diagnostic method for CMV is <strong>PCR</strong> or <strong>viral culture</strong> on <strong>urine</strong>.</p>\n<p>Since <strong>not</strong> all affected infants are <strong>viremic</strong> at birth, <strong>urine</strong>&nbsp;is a&nbsp;more <strong>reliable</strong> sample than blood.&nbsp;</p>\n<p>Intrauterine growth restriction (<strong>IUGR</strong>), <strong>prematurity</strong>, and hepatosplenomegaly raise the suspicion of <strong>congenital infection</strong>. <strong>Hepatosplenomegaly</strong>, <strong>jaundice</strong>, pneumonitis, <strong>petechiae</strong>, and <strong>meningoencephalitis</strong> are common to toxoplasmosis, rubella, CMV, herpes simplex virus (HSV), enteroviruses and syphilis. <strong>Hydrocephalus</strong> is seen in CMV, toxoplasmosis, HSV, and rubella.</p>\n<p>The characteristic clinical features of various congenital infections are described in the table below:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Congenital infections</strong></td>\n<td><strong>Characteristic</strong> <strong>features</strong></td>\n</tr>\n<tr>\n<td>Cytomegalovirus (CMV)</td>\n<td>\n<p><strong>Periventricular calcifications</strong></p>\n<p>Microcephaly</p>\n</td>\n</tr>\n<tr>\n<td>Toxoplasmosis</td>\n<td>\n<p>Chorioretinitis&nbsp;</p>\n<p><strong>Diffuse intracranial calcifications&nbsp;</strong></p>\n<p>Hydrocephalus&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>Rubella</td>\n<td>\n<p><strong>Sensorineural hearing loss</strong></p>\n<p><strong>Salt-and-pepper</strong> retinopathy</p>\n<p>Cataract</p>\n<p>Glaucoma</p>\n<p>Congenital defects like <strong>patent ductus arteriosus</strong></p>\n</td>\n</tr>\n<tr>\n<td>Herpes simplex virus (HSV)</td>\n<td>\n<p><strong>Vesicles</strong></p>\n<p>Microcephaly</p>\n</td>\n</tr>\n<tr>\n<td>Syphilis</td>\n<td>\n<p>Bone lesions (osteochondritis, periostitis)</p>\n<p>Maculopapular rashes</p>\n</td>\n</tr>\n<tr>\n<td>Enterovirus&nbsp;(polio, rhinovirus, hepatitis A)</td>\n<td>\n<p>Myocarditis</p>\n<p>Paralysis</p>\n</td>\n</tr>\n<tr>\n<td>Varicella zoster virus</td>\n<td>\n<p><strong>Limb hypoplasia</strong></p>\n<p>Cicatricial skin lesions</p>\n<p>Cortical atrophy</p>\n</td>\n</tr>\n<tr>\n<td>Zika virus</td>\n<td>\n<p><strong>Subcortical calcifications</strong></p>\n<p>Microcephaly</p>\n<p>Congenital contractures (arthrogryposis)</p>\n</td>\n</tr>\n<tr>\n<td>HIV</td>\n<td>\n<p>Thrush</p>\n<p><strong>Failure to thrive</strong></p>\n<p>Recurrent bacterial infections</p>\n<p><strong>Calcification of basal ganglia</strong></p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The triad of congenital CMV infection includes <strong>intracranial</strong> <strong>calcifications</strong> (periventricular), <strong>microcephaly</strong>, and <strong>chorioretinitis</strong>.</p>\n<p>Most CMV transmission occurs in the <strong>first</strong> <strong>trimester</strong>. The <strong>risk</strong> of transmission is high in the <strong>third</strong> trimester. 90% of the infected babies are <strong>asymptomatic</strong> and have lesser chances of having late sequelae.</p>\n<p>In symptomatic individuals, <strong>ganciclovir</strong> can<strong> limit hearing loss</strong> and improve the developmental outcome, while there is no definitive management for congenital CMV infection.</p>\n<p>The image below shows periventricular calcification in the head CT seen in CMV infection:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a723c4c17a8143848b294942b75f2f68x1280x1280.PNG\" alt=\"Explanation Image\"><p>The image below shows a <strong>blueberry muffin rash</strong>, seen in <strong>TORCH</strong> complex infections and <strong>neuroblastoma</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d407d23ea0944e088269751a90b6e607x1280x1144.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA4241",
      "difficulty": "medium"
    },
    {
      "text": "A 5-year-old child brought to the hospital with a history of loose stools. The mother says he is irritable and drinks water hastily when given. On examination, eyes are sunken and during the skin pinch test, the skin retracted within two seconds but not immediately. What is the treatment for the child?",
      "choices": [
        {
          "id": 1,
          "text": "Administer the first dose of IV antibiotic and immediately refer to a higher center"
        },
        {
          "id": 2,
          "text": "Give oral fluids and ask the mother to continue the same and visit again the next day"
        },
        {
          "id": 3,
          "text": "Give zinc supplementation and oral rehydration solution only and ask mother to come back if some danger signs develop"
        },
        {
          "id": 4,
          "text": "Consider severe dehydration, start intravenous (IV) fluids, IV antibiotics, and refer to a higher center"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The child in this scenario has some degree of dehydration, since the&nbsp;child is restless and irritable, drinks water readily, has sunken eyes, and the skin goes back slowly on the skin pinch test (&lt;2 seconds) with sunken eyes.</p>\n<p>Treatment includes oral rehydration therapy and zinc supplementation &nbsp;according to WHO Integrated Management of Neonatal and Childhood Diseases (IMNCI) Protocol, Plan B.</p>\n<p>WHO IMNCI PLANS:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f174f3e0e9654f8898e1d3176b16b078x510x428.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/faa30532230b4f2a8f6be81f7d14f35bx1280x601.GIF\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Symptoms associated with different levels of dehydration</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Symptoms</strong></span></td>\n<td><span><strong>No or minimal dehydration</strong></span></td>\n<td><span><strong>Mild to moderate dehydration</strong></span></td>\n<td><span><strong>Severe dehydration</strong></span></td>\n</tr>\n<tr>\n<td><span><strong>Loss of body weight</strong></span></td>\n<td><span>&lt;3%</span></td>\n<td><span>3&ndash;9%</span></td>\n<td><span>&gt;9%</span></td>\n</tr>\n<tr>\n<td><span><strong>Mental status</strong></span></td>\n<td><span>Well; <strong>alert</strong></span></td>\n<td><span>Fatigued or&nbsp;<strong>irritable</strong></span></td>\n<td><span><strong>Lethargic </strong>or unconscious</span></td>\n</tr>\n<tr>\n<td><span><strong>Thirst</strong></span></td>\n<td><span>Drinks normally</span></td>\n<td><span><strong>Thirsty</strong>; eager to drink</span></td>\n<td><span>Drinks poorly</span></td>\n</tr>\n<tr>\n<td><span><strong>Heart rate</strong></span></td>\n<td><span>Normal</span></td>\n<td><span>Normal to increased</span></td>\n<td><span>Tachycardia</span></td>\n</tr>\n<tr>\n<td><span><strong>Quality of pulse</strong></span></td>\n<td><span>Normal</span></td>\n<td><span>Normal to decreased</span></td>\n<td><span>Weak, thready or impalpable</span></td>\n</tr>\n<tr>\n<td><span><strong>Skin turgor test</strong></span></td>\n<td><span>Instant recoil</span></td>\n<td><span><strong>Recoil in &lt;2</strong> <strong>sec</strong></span></td>\n<td><span>Recoil in &gt;2 sec</span></td>\n</tr>\n<tr>\n<td><span><strong>Capillary refill</strong></span></td>\n<td><span>Normal</span></td>\n<td><span>Prolonged</span></td>\n<td><span>Prolonged</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Treatment of dehydration based on severity</h3><p><strong>Plan A</strong>: For no dehydration or minimal dehydration.&nbsp;ORS is administered after each loose stool.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Amount&nbsp;</strong></td>\n</tr>\n<tr>\n<td>&lt;2 years</td>\n<td>50&ndash;100 mL</td>\n</tr>\n<tr>\n<td>2-10 years</td>\n<td>100&ndash;200 mL</td>\n</tr>\n<tr>\n<td>&gt;10 years</td>\n<td>As much fluid as they want</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Plan B</strong>: For moderate dehydration.</p>\n<p>The amount of oral rehydration solution (ORS) to be given is <strong>75 mL/kg body weight</strong> (wt &times; 75).</p>\n<p><strong>Plan C</strong>: Severe dehydration</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td>First, give<strong> 30 mL/kg in</strong></td>\n<td>Followed by <strong>70 mL/kg in</strong></td>\n<td>Total<strong> 100 mL/kg in</strong></td>\n</tr>\n<tr>\n<td>Infants (under 12 months)</td>\n<td>1 hr</td>\n<td>5 hrs</td>\n<td>&nbsp;6 hrs</td>\n</tr>\n<tr>\n<td>Older</td>\n<td>30 min</td>\n<td>2&frac12; hrs</td>\n<td>&nbsp;3 hrs</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note:&nbsp;</strong><strong>Ringer lactate</strong> (ideal) or normal saline is used as intravenous fluids.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0768",
      "difficulty": "easy"
    },
    {
      "text": "What is the cause of hypercoagulability in nephrotic syndrome?\n<div class='question-desc-html'><p>A) Vascular stasis due to hemoconcentration and intravascular volume depletion<br />B) Decrease in hepatic production of fibrinogen<br />C) Urinary loss of antithrombin III and protein S</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "A, B and C"
        },
        {
          "id": 2,
          "text": "A & C"
        },
        {
          "id": 3,
          "text": "B & C"
        },
        {
          "id": 4,
          "text": "None of the above"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Hypercoagulability</strong> in <strong>nephrotic syndrome</strong> is due to the following factors:</p>\n<ul>\n<li>Vascular <strong>stasis</strong> due to hemoconcentration and intravascular volume depletion.</li>\n<li><strong>Increase</strong>(not decrease) in hepatic production of fibrinogen.</li>\n<li>Urinary <strong>loss of antithrombin III and protein S</strong>.</li>\n<li>Increased platelet number and aggregability.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4340",
      "difficulty": "medium"
    },
    {
      "text": "According to the expanded new Ballard score, which of the following criteria for neuromuscular maturity shows a popliteal angle?",
      "choices": [
        {
          "id": 1,
          "text": "D only"
        },
        {
          "id": 2,
          "text": "C & D"
        },
        {
          "id": 3,
          "text": "E only"
        },
        {
          "id": 4,
          "text": "F only"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>According to the expanded new ballard score, criteria for neuromascular maturity given in row \"D\" depicts popliteal angle.</p>\n<p><strong>Expanded New Ballard score:</strong></p>\n<ul>\n<li><strong>5 points (maximum score)</strong> can be assigned to only 2 of the criteria:\n<ul>\n<li><strong>Popliteal angle</strong> (criteria for neuromuscular maturity)</li>\n<li><strong>Skin </strong>(criteria for physical maturity)</li>\n</ul>\n</li>\n<li>For all other criteria, 4 is the maximum score.</li>\n<li>-1 is the minimum score for all criteria except posture and arm recoil. For both these, 0 is the minimum score.</li>\n</ul><p>New Ballard Score:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9401c700938d448fbeaefa1abab5fe4bx1280x1696.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/33830b07fcac4225a27363aa0d53287c.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4342",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following medicine taken during pregnancy is responsible for defect seen in child below?",
      "choices": [
        {
          "id": 1,
          "text": "Ferrous sulfate"
        },
        {
          "id": 2,
          "text": "Isotretinoin"
        },
        {
          "id": 3,
          "text": "Folic acid"
        },
        {
          "id": 4,
          "text": "Metoclopramide"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Facial defects including cleft lip seen in this child is characteristic of teratogenic effect of isoretinoin.</p>\n<p>Systemic retinoids are highly teratogenic .There is no safe dose during pregnancy. Common malformations include craniofacial,cardiovascular,thymic and central nervous system abnormalities.</p><hr><h3>Related Pearl: Teratogenic drugs and the birth defects</h3><table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Adverse effects</strong></td>\n</tr>\n<tr>\n<td>Penicillamine</td>\n<td>Cutis laxa syndrome</td>\n</tr>\n<tr>\n<td><strong>Lithium</strong></td>\n<td><strong>Ebstein anomaly</strong></td>\n</tr>\n<tr>\n<td>Isotretinoin</td>\n<td>Facial-ear anomalies, heart disease, CNS anomalies</td>\n</tr>\n<tr>\n<td>Progesterone</td>\n<td>Masculinization of the female fetus</td>\n</tr>\n<tr>\n<td>Quinine</td>\n<td>Abortion, thrombocytopenia, deafness</td>\n</tr>\n<tr>\n<td>Topiramate</td>\n<td>Cleft lip</td>\n</tr>\n<tr>\n<td><strong>Valproate</strong></td>\n<td>Spina bifida, limb defects,<strong>autism spectrum disorder</strong>, facial and cardiac anomalies,<strong>Coarctation of the aorta</strong>, Aortic stenosis, Pulmonary atresia, Ventricular Septal Defect.</td>\n</tr>\n<tr>\n<td><strong>Vitamin D</strong></td>\n<td><strong>Supravalvular aortic stenosis</strong></td>\n</tr>\n<tr>\n<td><strong>Warfarin</strong></td>\n<td>Fetal bleeding, <strong>hypoplastic nasal structures</strong></td>\n</tr>\n<tr>\n<td><strong>Statins</strong></td>\n<td>Vertebral, anal, cardiac, tracheoesophageal fistula, renal, arterial, limb (<strong>VACTERAL</strong>) defects</td>\n</tr>\n<tr>\n<td><strong>Phenytoin</strong></td>\n<td>Ventricular septal defect, Atrial Septal Defect, Coarctation of the aorta, Patent Ductus Arteriosus</td>\n</tr>\n<tr>\n<td>ACE inhibitors and ARBs</td>\n<td>\n<p>Hypoplasia of organs, anuria, irreversible renal failure</p>\n</td>\n</tr>\n<tr>\n<td>Carbimazole and Methimazole</td>\n<td>\n<p>Choanal atresia, aplasia cutis, tracheoesophageal fistula and fetal goiter</p>\n</td>\n</tr>\n<tr>\n<td>Alcohol</td>\n<td>Atrial Septal Defect, Ventricular Septal Defect</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/414955eacb164de7b76b10922113edf7.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4343",
      "difficulty": "easy"
    },
    {
      "text": "An anxious mother brought her 4-year-old daughter to the pediatrician. The girl was passing loose, bulky stools for the past 4 days. This was often associated with pain in the abdomen. The pediatrician ordered stool examination, which showed the following organisms. Which vitamin deficiency is the child at the greatest risk for?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin B1 deficiency"
        },
        {
          "id": 2,
          "text": "Vitamin A deficiency"
        },
        {
          "id": 3,
          "text": "Vitamin B6 deficiency"
        },
        {
          "id": 4,
          "text": "Vitamin C deficiency"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The stool examination (image) shows&nbsp;<strong>pear-shaped trophozoites</strong> having two nuclei and a flagellum, typical of <strong><em>Giardia lamblia</em>.&nbsp;</strong>Giardiasis is associated with&nbsp;a deficiency of fat-soluble vitamins like vitamin A.</p>\n<p><em>Giardia lamblia&nbsp;</em>is transmitted via contaminated drinking water.</p>\n<p>Clinical features include acute infectious diarrhea or <strong>chronic diarrhea</strong>, failure to thrive, and abdominal pain. Stools initially may be profuse and watery and later become greasy and <strong>foul-smelling</strong>. Stools do not contain blood, mucus, or leukocytes. It is associated with fat-soluble vitamin deficiencies, iron deficiency, and growth stunting.</p>\n<p>Diagnosis is done by <strong>stool enzyme immunoassay (EIA)</strong> or direct fluorescent antibody tests for<em> Giardia</em> antigens; EIA is superior to microscopy.</p>\n<p>Treatment includes tinidazole and nitazoxanide.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b254d177a26d47a192da5d336c15f58d.jpg"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5843",
      "difficulty": "easy"
    },
    {
      "text": "As per revised 2014 WHO  guidelines which of the following pneumonia case is safe to treat at home?",
      "choices": [
        {
          "id": 1,
          "text": "Convulsions"
        },
        {
          "id": 2,
          "text": "Severe malnutrition"
        },
        {
          "id": 3,
          "text": "Chest indrawing"
        },
        {
          "id": 4,
          "text": "None of the above"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The revised 2014 WHO guidelines states that it is safe to treat chest indrawing pneumonia at home.</p>\n<p>However, a child who is HIV positive and has chest indrawing needs to be referred for inpatient treatment.</p>\n<p>Only those children who have the following general danger signs are classified as having &ldquo;severe pneumonia&rdquo; and need to be referred to a higher level (hospital admission):</p>\n<ul>\n<li>Not able to drink</li>\n<li>Persistent vomiting</li>\n<li>Convulsions lethargic or unconscious</li>\n<li>Stridor in a calm child</li>\n<li>Severe malnutrition</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4344",
      "difficulty": "medium"
    },
    {
      "text": "A child with rickets not responding to treatment is being evaluated. Investigations show serum calcium level of 9 mg/dL, low phosphate level of 2 mg/dL,  elevated alkaline phosphatase, and normal parathyroid hormone levels with normal arterial blood gas levels. What is the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Renal tubular acidosis"
        },
        {
          "id": 2,
          "text": "Hypophosphatemic rickets"
        },
        {
          "id": 3,
          "text": "Chronic kidney disease"
        },
        {
          "id": 4,
          "text": "Vitamin D-dependant rickets, type 2"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This clinical scenario of a child with a history of treatment-resistant rickets, normal levels of calcium (9 to 11 mg/dL), parathyroid hormone, arterial blood gas (ABG), with<strong> decreased phosphate</strong> (normal, 2.5 to 4.3 mg/dL), and elevated levels of alkaline phosphatase (normal, 33 to 96 U/L) is suggestive of <strong>hypophosphatemic rickets</strong>.</p>\n<p><strong>Hypophosphatemic rickets:</strong></p>\n<p>X-linked dominant hypophosphatemic rickets is the&nbsp;<strong>most common genetic cause</strong>&nbsp;of rickets while the most common, overall is nutritional vitamin D deficiency.&nbsp;<strong>PHEX&nbsp;gene</strong>&nbsp;(<strong>ph</strong>osphate-regulating&nbsp;<strong>e</strong>ndopeptidase on&nbsp;<strong>x</strong>&nbsp;chromosome) products are responsible for the&nbsp;<strong>inactivation of phosphatonin</strong>. Mutation of this&nbsp;PHEX&nbsp;leads to increased phosphatonin (FGF 23) levels, and hence, the <strong>excretion of phosphorous</strong> is <strong>increased</strong>. This is also associated with <strong>impaired</strong> renal tubular <strong>reabsorption</strong> of phosphate leading to its excess excretion.</p>\n<p>The chart attached below summarizes the evaluation of hypophosphatemic rickets.</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a7c805ae6ab94a9db6b9d957014e9d99x1280x1837.8561354019746.JPEG\" alt=\"Explanation Image\"><p><strong>Treatment-resistant rickets :</strong></p>\n<p>Patients respond well to a combination of <strong>oral phosphorus</strong> and <strong>1,25-D (calcitriol)</strong>. Frequent dosing helps prevent prolonged decrements in serum phosphorus levels because there is a rapid decline after each dose. In addition, frequent dosing decreases diarrhea, which is a complication of high-dose oral phosphorus.&nbsp;<strong><br /></strong></p><hr><h3>Related Pearl: Vitamin D activation and Rickets</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fc2bbad956284f25ac60ba74c376ac0ex780x802.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Radiological Features of Rickets</h3><p>Radiological features of rickets:</p>\n<ul>\n<li><strong>Loss of provisional zone of calcification: </strong>earliest radiological finding of rickets.</li>\n<li>Delayed appearance of the epiphysis</li>\n<li><strong>Widening of growth plate:</strong>normal width of growth plate is 2-4mm. It is increased in cases of rickets due to excessive accumulation of uncalcified osteoid at the growth plate.</li>\n<li><strong>Cupping of metaphysis:</strong>normally metaphysis meets epiphysis as a smooth line of sclerosis. But in rickets the line is absent and the metaphyseal ends appear irregular and the cartilage accumulating in the growth plate creates a depression in the metaphysis causing cupping.</li>\n<li><strong>Fraying</strong>:indistinct margins of the metaphysis</li>\n<li><strong>Bowing of diaphysis,</strong>with thinning of cortices</li>\n<li>In healing rickets, zone of calcification becomes denser.</li>\n</ul>\n<p>The above features are prominent at the growth plates where growth is greatest:</p>\n<ul>\n<li>Knee: distal femur, proximal tibia</li>\n<li>Wrist: especially the ulna</li>\n<li>Anterior rib ends: <strong>rachitic rosary</strong></li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3fb9e16daa324d32bc69ad013a616401x1280x1694.JPEG\" alt=\"Pearl Image\"><p>The below image shows bowing of legs in rickets.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2540c743846448f9a7b302483397230ax256x406.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Biochemical parameters in metabolic bone diseases</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Metabolic bone disease</strong></p>\n</td>\n<td><strong>Calcium</strong></td>\n<td><strong>PTH</strong></td>\n<td><strong>Phosphate</strong></td>\n<td><strong>ALP</strong></td>\n</tr>\n<tr>\n<td>\n<p>Rickets / Osteomalacia</p>\n</td>\n<td>&nbsp;&darr;/N</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&darr;</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Primary</p>\n<p>hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp;&nbsp;&nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&darr;</td>\n<td>&nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Secondary</p>\n<p>hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&darr;</td>\n<td>&nbsp;&nbsp; &uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Tertiary hyperparathyroidism</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp; &uarr;</td>\n<td>&nbsp; &nbsp; &nbsp; &nbsp;&uarr;</td>\n<td>&nbsp; &nbsp;&uarr;</td>\n</tr>\n<tr>\n<td>Osteoporosis</td>\n<td>&nbsp; &nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp; &nbsp; N</td>\n<td>&nbsp; N</td>\n</tr>\n<tr>\n<td>\n<p>Paget's&nbsp;disease</p>\n</td>\n<td>&nbsp; &nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp;N</td>\n<td>&nbsp; &nbsp; &nbsp; N</td>\n<td>&nbsp; &uarr;</td>\n</tr>\n<tr>\n<td>\n<p>Osteopetrosis</p>\n</td>\n<td>&nbsp; &darr;/N</td>\n<td>&uarr;/N</td>\n<td>&nbsp; &nbsp; &darr;/N</td>\n<td>&nbsp; N</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;&uarr;: Increased,&nbsp;&nbsp;&darr;: Decreased, N: Normal</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1196",
      "difficulty": "medium"
    },
    {
      "text": "An 8 days old child presents with yellow sclera, whitish stool and turmeric colour urine on 3rd day of septicaemia on broad spectrum antibiotics , the likely diagnosis is -",
      "choices": [
        {
          "id": 1,
          "text": "Galactosidase deficiency"
        },
        {
          "id": 2,
          "text": "Ammonia toxicity"
        },
        {
          "id": 3,
          "text": "Galactose 1- phosphate uridyl transferase deficiency"
        },
        {
          "id": 4,
          "text": "Glucose 6 phosphatase deficiency"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Feature of conjugated bilirubinemia on 3<sup>rd</sup> day accompanied by sepsis in a neonate suggests diagnosis of Galactosemia, in which there is deficiency of <strong>galactose 1 phosphate uridyl transferase</strong>.</p>\n<p><strong>Galactosemia:</strong></p>\n<ul>\n<li>Deficiency of galactose 1-phosphate uridyl transferase.</li>\n<li>Autosomal recessive disorder</li>\n<li>Newborn infant receives high amounts of lactose from breast milk or other formulas which consists of equal amounts of glucose and galactose. Without the transferase enzyme the infant is unable to metabolize galactose 1 phosphate,the accumlation of which results in injury to kidney,liver and brain.This injury may begin prenatally in affected fetus.</li>\n<li>Patients with galactosemia are at increased risk for e.coli neonatal sepsis.</li>\n<li>Treatment:\n<ul>\n<li><strong>Non lactose containing milk</strong> substitutes should be used.</li>\n<li>Elimination of galactose from diet along with adequate <strong>calcium supplementation</strong> reverses growth failure and renal and hepatic dysfunction.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4346",
      "difficulty": "easy"
    },
    {
      "text": "Sheila, a widowed maid brings her youngest child to your OPD with complaints of cough and cold. She has not been able to feed her kids after the lockdown affected her work. The image of the child is shown below.  Which of the following is least likely to be seen in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Baggy pant appearance"
        },
        {
          "id": 2,
          "text": "Reduced mid arm circumferance"
        },
        {
          "id": 3,
          "text": "Apathy"
        },
        {
          "id": 4,
          "text": "Pitting not seen"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The image shows a child with <strong>marasmus </strong>which is <strong>not associated with apathy</strong>. Apathy is a psychomotor change seen in kwashiorkor.</p><hr><h3>Related Pearl: Differences between Marasmus and Kwashiorkar</h3><table>\n<tbody>\n<tr>\n<td><span><strong>Marasmus</strong></span></td>\n<td><span><strong>Kwashiorkor</strong></span></td>\n</tr>\n<tr>\n<td>Seen in infants less than 1 year of age</td>\n<td>\n<p>Seen in older children</p>\n<p>(6 months to 3 years of age)</p>\n</td>\n</tr>\n<tr>\n<td>Total calorie deficit</td>\n<td>Protein deficit</td>\n</tr>\n<tr>\n<td><span>No edema</span></td>\n<td><span>Edema is prominent</span></td>\n</tr>\n<tr>\n<td>\n<p><span>Voracious appetite</span></p>\n<p><span>No apathy</span></p>\n</td>\n<td>\n<p><span>Loss of appetite</span></p>\n<p><span>Apathy</span></p>\n</td>\n</tr>\n<tr>\n<td><span>Severe muscle wasting</span></td>\n<td><span>Muscle wasting mild or absent</span></td>\n</tr>\n<tr>\n<td><span>Prominent ribs</span></td>\n<td>Protuberant abdomen</td>\n</tr>\n<tr>\n<td>\n<p>No Fatty liver</p>\n<p>No subcutaneous fat</p>\n</td>\n<td>\n<p><span>Fatty liver</span></p>\n<p><span> Subcutaneous fat preserved</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Special features:</p>\n<ol>\n<li>Alert</li>\n<li>Loose wrinkled skin&nbsp;</li>\n<li>Baggy pant appearance</li>\n</ol>\n</td>\n<td>\n<p><span>Special features:</span></p>\n<ol>\n<li><span>Moon face</span></li>\n<li><span>Flaky paint dermatosis</span></li>\n<li><span>Flag sign</span></li>\n</ol>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>The image below shows&nbsp;<strong>Flag sign </strong>characterised by&nbsp;alternating bands of hypopigmented and normal pigmented areas on the hair strand.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2bf9b82662154bc1bb27ad58c04649f4x1280x1364.851904090268.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>The image below shows a child with an old wrinkled old man appearance.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f0411a009a6342ee9a61833d387a7fc3x720x932.PNG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p>The image highlights the differentiating clinical features between marasmus and kwashiorkor</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5b5cb2c46782497abb5654b4d4ca3b25x800x512.PNG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/dab52325ee3d4091adba30dd4d3097dd.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4347",
      "difficulty": "medium"
    },
    {
      "text": "Which fungal infection spreads in neonates through the care giver's hand?",
      "choices": [
        {
          "id": 1,
          "text": "Candida albicans"
        },
        {
          "id": 2,
          "text": "Candida parapsilosis"
        },
        {
          "id": 3,
          "text": "Candida tropicalis"
        },
        {
          "id": 4,
          "text": "Candida glabrata"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><em><strong>Candida</strong> <strong>parapsilosis</strong></em> is increasingly responsible for hospital outbreaks, and the hands of healthcare workers may be predominant environment sources.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3100",
      "difficulty": "hard"
    },
    {
      "text": "A male baby born at term from uncomplicated delivery develops respiratory distress shortly after birth. The chest x-ray shows a diffuse ground-glass appearance of lung fields. Surfactant replacement and mechanical ventilation fail to improve hypoxemia. There is a history of death of a term male sibling at 1 month of age due to respiratory distress. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Neonatal pulmonary alveolar proteinosis"
        },
        {
          "id": 2,
          "text": "Meconium aspiration syndrome"
        },
        {
          "id": 3,
          "text": "Hyaline membrane disease"
        },
        {
          "id": 4,
          "text": "Transient tachypnea of newborn"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical history of <strong>respiratory distress</strong> and <strong>no response </strong>to<strong> surfactant</strong> therapy in a newborn and a <strong>family history</strong> of sibling death point toward a diagnosis of <strong>n</strong><strong>eonatal pulmonary alveolar proteinosis&nbsp;</strong>(PAP).</p>\n<p>It is a disorder characterized by <strong>intra-alveolar accumulation</strong> of pulmonary surfactant due to abnormal surfactant production or impaired clearance by alveolar macrophages. Inherited PAP occurs due to the dysfunction of various surfactant proteins.</p>\n<div class=\"page\" title=\"Page 3997\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 4001\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Pulmonary alveolar proteinosis</strong>&nbsp;is classified into primary and secondary PAP. Primary pulmonary alveolar proteinosis&nbsp;is caused due to disruption of granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling. Secondary PAP is caused due to several different diseases that reduce alveolar macrophage number or function.</p>\n</div>\n</div>\n</div>\n</div>\n<p>In the neonatal period, the disease may manifest as a severe respiratory failure whereas in older children it has an insidious onset of chronic interstitial lung disease.&nbsp;Infants present with symptoms of dyspnea, fatigue, cough, weight loss, chest pain, or hemoptysis.</p>\n</div>\n</div>\n</div>\n<p>Chest x-ray shows <strong>diffuse alveolointerstitial infiltrates</strong> presenting as <strong>ground-glass opacities</strong>. <strong>Lung biopsy </strong>is the gold standard investigation to diagnose PAP<strong>.&nbsp;</strong>Latex agglutination tests for the presence of anti&ndash;GM-CSF antibodies in BAL fluid or blood can also be done. They are highly sensitive and specific for the autoimmune forms of alveolar proteinosis.</p>\n<p>The disease is <strong>progressive</strong> and is <strong>refractory to surfactant replacement therapy</strong>.<strong>&nbsp;</strong>Neonates with&nbsp;severe respiratory failure require mechanical ventilation and can also be treated with extracorporeal membrane oxygenation.&nbsp;Neonatal intensive care interventions and lung transplantation have been successful in a few cases. A <strong>total&nbsp;lung lavage</strong>&nbsp;is a therapeutic option for patients with childhood PAP.&nbsp;Subcutaneous or inhaled administration of <strong>recombinant GM-CSF</strong> may improve pulmonary function in some adults with later-onset PAP.&nbsp;</p>\n<p>Other options:<br /><br />Option B: <strong>Meconium aspiration syndrome</strong> (MAS) presents immediately after birth, with features of <strong>respiratory distress </strong>due to<strong> aspiration of meconium</strong> in utero, resulting in <strong>airway obstruction</strong>. Most cases improve well with supportive care and mechanical ventilation.&nbsp;</p>\n<div class=\"page\" title=\"Page 1470\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Option C: <strong>Hyaline membrane disease</strong> occurs in <strong>premature infants</strong> due to <strong>surfactant deficiency</strong>. Distress ensues within a few minutes of birth. If untreated, it may result in respiratory failure. <strong>Surfactant replacement therapy</strong> and mechanical ventilation will greatly improve the condition.</p>\n<p>Option D: <strong>Transient tachypnea of the newborn</strong> is <strong>self-limiting</strong> tachypnea occurring in full-term infants due to <strong>reduced clearance of fetal lung fluid</strong>. Treatment is mainly <strong>supportive</strong>.</p>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Radiologic features of the major respiratory distress disorders in newborns</h3><p><strong> Congenital Diaphragmatic Hernia</strong></p>\n<ul>\n<li>Mediastinal shift</li>\n<li>Bowel loops in the left hemithorax</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/26467efcc64f448399d64ee0549179cfx439x599.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Respiratory Distress Syndrome</strong></p>\n<ul>\n<li>Low lung volume</li>\n<li>Symmetric ground-glass opacity (reticulogranular pattern)</li>\n<li>Air bronchogram</li>\n<li>White-out lung (severe disease)</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d6a4922ed6bf4e358741affc867a3976x557x235.JPEG\" alt=\"Pearl Image\"><p>Chest radiograph&nbsp;<strong>(A)</strong>&nbsp;on Day 2: shows reticulogranular opacities throughout both lungs with prominent air bronchograms. The cardiac silhouette is preserved and both lungs are hypoaerated.</p>\n<p>Chest radiograph&nbsp;<strong>(B)</strong>&nbsp;on Day 9 (<strong>untreated</strong>): shows more severe changes. There is obliteration of the cardiac and diaphragmatic contours due to marked opacification, giving a complete&nbsp;<strong>&lsquo;white out&rsquo;</strong>&nbsp;<strong>appearance</strong></p><p>&nbsp;<strong>Meconium Aspiration Syndrome</strong></p>\n<ul>\n<li>Hyperinflation</li>\n<li>Patchy infiltrates</li>\n<li>Coarse streaking</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ab0054d9b6a648768997515115ee6e3dx744x740.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4348",
      "difficulty": "easy"
    },
    {
      "text": "If a child presents with albinism he should be evaluated for:",
      "choices": [
        {
          "id": 1,
          "text": "ENT consultation"
        },
        {
          "id": 2,
          "text": "Eye consultation"
        },
        {
          "id": 3,
          "text": "Electrocardiography"
        },
        {
          "id": 4,
          "text": "Neurosurgery"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>If a child presents with albinism, he should be evaluated for an <strong>eye consultation.</strong></p>\n<p><strong>Oculocutaneous albinism type 1(OCA1)</strong> is characterized by great reduction or absence&nbsp; of tyrosinase activity. OCA1A the most severe form is characterized by photophobia, nystagmus, defective visual acuity, white hair and white skin.</p>\n<p><strong>OCA2</strong> ranges from normal to closely resembling type 1 albinism. It is the most common form seen worldwide. Progressive improvement in visual acuity and nystagmus occurs with aging.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4349",
      "difficulty": "medium"
    },
    {
      "text": "A young girl who was grossly emaciated and undernourished was started on partial parenteral nutrition together with enteral nutrition via a nasogastric tube. In the first week, which among the following would be the hallmark for the development of refeeding syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperphosphatemia"
        },
        {
          "id": 2,
          "text": "Hypophosphatemia"
        },
        {
          "id": 3,
          "text": "Hypokalemia"
        },
        {
          "id": 4,
          "text": "Hyperkalemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>hallmark of refeeding syndrome</strong> is the development of<strong> severe hypophosphatemia</strong>.</p>\n<p>Refeeding syndrome is a complication of the acute nutritional rehabilitation of <strong>children who are undernourished</strong> from any cause, and it may follow <strong>overly aggressive enteral or parenteral alimentation.</strong></p>\n<p>When excessive carbohydrates are administered, the resultant increase in serum insulin levels may produce the following:</p>\n<ol>\n<li><strong>Hypophosphatemia</strong> (hallmark)</li>\n<li>Hypokalemia</li>\n<li>Hypomagnesemia</li>\n</ol>\n<p>A controlled <strong>transition over 3 days</strong>&nbsp;from F-75 to F-100 is recommended by the WHO for treating malnutrition, to prevent refeeding syndrome.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0493",
      "difficulty": "medium"
    },
    {
      "text": "Identify the instrument shown.",
      "choices": [
        {
          "id": 1,
          "text": "Spring balance"
        },
        {
          "id": 2,
          "text": "Beam balance"
        },
        {
          "id": 3,
          "text": "Electronic weighing scale"
        },
        {
          "id": 4,
          "text": "Salter scale"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The instrument shown is <strong>salter scale.</strong></p>\n<p>It is accepted by <strong>UNICEF</strong> and the central govt. as a mechanical machine used for weighing children from age 1-5 yr. It is donated by UNICEF in various anganwadi centres of different states for weighing children and recording the growth monitoring chart.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5601934f996244949af768603f696f69.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4350",
      "difficulty": "medium"
    },
    {
      "text": "A primary school teacher notices a peculiar behavior in one of her pupils. Whenever he plays with his friends, she notices that her fingers and lips turn blue. The child then squats for sometime after which he feels better. Which of the following does not occur during squatting?",
      "choices": [
        {
          "id": 1,
          "text": "It increases  the systemic vascular resistance"
        },
        {
          "id": 2,
          "text": "It increases the magnitude of right-to-left shunt"
        },
        {
          "id": 3,
          "text": "Leads to trapping of deoxygenated blood in lower limbs"
        },
        {
          "id": 4,
          "text": "Both A and C"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Squatting <strong>decreases the magnitude of the right-to-left shunt </strong>in a child with <strong>tetralogy of Fallot</strong> (TOF) .</p>\n<p>The child feels comfortable while squatting due to two compensatory mechanisms:</p>\n<ul>\n<li>Increasing systemic vascular resistance and, thus,&nbsp;<strong>decreasing the magnitude of the right-to-left shunt</strong> across the ventricular septal defect (VSD). Therefore, more blood goes to the&nbsp;lungs for oxygenation.</li>\n<li><strong>Trapping deoxygenated venous blood</strong> in the lower limbs.</li>\n</ul>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0589",
      "difficulty": "medium"
    },
    {
      "text": "An 18 month old baby who hasn't received immunisation so far, was brought to the clinic. Which of the following vaccines can be given?",
      "choices": [
        {
          "id": 1,
          "text": "Pentavalent vaccine only"
        },
        {
          "id": 2,
          "text": "OPV+DPT+Measles 1st dose"
        },
        {
          "id": 3,
          "text": "BCG + OPV + MMR"
        },
        {
          "id": 4,
          "text": "OPV + DPT booster"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Vaccines which can be given to an 18 month old unimmunized baby brought to the clinic for the first time are OPV+DPT+Measles 1st dose.</p>\n<p>&nbsp;</p><hr><h3>Related Pearl: National Immunization Schedule (India)</h3><table>\n<tbody>\n<tr>\n<td><strong>Vaccine</strong></td>\n<td><strong>When to give</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Route</strong></td>\n<td><strong>Site</strong></td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Pregnant Women</strong></td>\n</tr>\n<tr>\n<td>Td-1</td>\n<td>\n<p>Early in pregnancy</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-2</td>\n<td>\n<p>4 weeks after Td-1*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td-Booster</td>\n<td>\n<p>If received 2 Td doses in a pregnancy<br />within the last 3 yrs*</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Infants</strong></td>\n</tr>\n<tr>\n<td>BCG</td>\n<td>\n<p>At birth or as early as possible until oneyear of age</p>\n</td>\n<td>0.1 mL (0.05 mL until<br />1 month<br />age)</td>\n<td>Intra-dermal</td>\n<td>Left upper arm</td>\n</tr>\n<tr>\n<td>Hepatitis B - BirthDose</td>\n<td>\n<p>At birth or as early as possible within 24 hrs</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateralside of mid-thigh</td>\n</tr>\n<tr>\n<td>OPV - 0</td>\n<td>\n<p>At birth or as early as possible withinthe first 15 days</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>OPV-1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until 5 years of age)</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>Pentavalent1, 2 &amp; 3</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>0.5 mL</td>\n<td>lntramuscular</td>\n<td>Antero-lateralside of mid-thigh</td>\n</tr>\n<tr>\n<td>Rotavirus</td>\n<td>\n<p>At 6 weeks, 10 weeks, &amp; 14 weeks (can be given until one year of age)</p>\n</td>\n<td>5drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>IPV</td>\n<td>\n<p>Two fractional doses at 6, 14 weeks </p>\n</td>\n<td>0.1 mL</td>\n<td>Intra-dermal two fractional dose</td>\n<td>Intra-dermal: right Upper arm (at 6, 14 weeks)<br /><br /></td>\n</tr>\n<tr>\n<td>\n<p>PCV</p>\n<p>(wherever applicable)</p>\n</td>\n<td>\n<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intramuscular</td>\n<td>Antero-lateralside of mid-thigh, right</td>\n</tr>\n<tr>\n<td>Measles/MR 1<sup>st</sup> Dose</td>\n<td>\n<p>9 completed months to 12 months<br />(Can be given till 5 years of age)</p>\n</td>\n<td>0.5ml</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm</td>\n</tr>\n<tr>\n<td>JE- 1**</td>\n<td>\n<p>9 completed months to 12 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular(killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>\n<p>Anterolateral aspect of mid-thigh/Left upper arm</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin A<br />(1st dose)</td>\n<td>\n<p>At9 completed months with measles Rubella</p>\n</td>\n<td>1 mL (1 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td colspan=\"5\"><strong>For Children</strong></td>\n</tr>\n<tr>\n<td>DPT booster-1</td>\n<td>\n<p>1624 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Antero-lateralside of mid-thigh </td>\n</tr>\n<tr>\n<td>Measles / MR 2<sup>nd </sup>dose</td>\n<td>\n<p>1624 months</p>\n</td>\n<td>0.5 mL</td>\n<td>Sub-cutaneous</td>\n<td>Right upper arm </td>\n</tr>\n<tr>\n<td>OPV booster</td>\n<td>\n<p>1624 months</p>\n</td>\n<td>2 drops</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>JE-2</td>\n<td>\n<p>1624 months</p>\n</td>\n<td>0.5 mL</td>\n<td>\n<p>Intramuscular (killed)/Subcutaneous (live attenuated)</p>\n</td>\n<td>Anterolateral aspect of mid-thigh/Left upper arm</td>\n</tr>\n<tr>\n<td>Vitamin A***<br />(2nd to 9<sup>th</sup> dose)</td>\n<td>\n<p>1618 months, followed byone dose every 6 months up to the age of 5 years</p>\n</td>\n<td>2mL (2 lakh IU)</td>\n<td>Oral</td>\n<td>Oral</td>\n</tr>\n<tr>\n<td>DPT booster 2</td>\n<td>\n<p>56 years</p>\n</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>Upper arm</td>\n</tr>\n<tr>\n<td>Td</td>\n<td>10 years &amp; 16 years</td>\n<td>0.5 mL</td>\n<td>Intra-muscular</td>\n<td>\n<p>Upper arm</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*Give Td-2 or booster doses before 36 weeks of pregnancy. However, give these even if more than 36 weeks have passed. Give Td to a woman in labor, if she has not previously received Td.</p>\n<p>**JE vaccine is introduced in select endemic districts after the campaigns. Intramuscular (killed inactivated) vaccine is gradually replacing the live attenuated vaccine. This change is because the killed vaccines are more effective and require fewer doses.</p>\n<p>***The 2nd to 9th doses of vitamin A can be administered to children 15 years old during biannual rounds, in collaboration with ICDS.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4359",
      "difficulty": "medium"
    },
    {
      "text": "You come across a child with growth hormone deficiency during your ward rounds. Which of the following features would you not expect in this child?",
      "choices": [
        {
          "id": 1,
          "text": "History of short stature at birth"
        },
        {
          "id": 2,
          "text": "High-pitched voice"
        },
        {
          "id": 3,
          "text": "Normal intelligence"
        },
        {
          "id": 4,
          "text": "Proportionate short stature"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Children with growth hormone deficiency usually have&nbsp;<strong>normal growth at birth. G</strong><strong>rowth retardation</strong>&nbsp;(decline in growth velocity) becomes apparent around <strong>1 year</strong> of age.&nbsp;</p>\n<p>Growth <strong>in-utero</strong> is dependant on <strong>genetic, environmental, nutrition</strong> and <strong>growth factors.</strong> GH levels peak at mid-gestation, increase at birth, and then reduce by 2 weeks of life. At around <strong>6 months</strong> of age, <strong>GH</strong> levels reach <strong>pre-pubertal levels</strong> and from there on have a major <strong>influence</strong> on <strong>growth.</strong>&nbsp;Thus the deficiency becomes apparent after a significant period of GH-dependent growth has occurred.&nbsp;</p>\n<p><strong>Characteristic</strong> features of <strong>growth hormone deficiency</strong> (<strong>Pituitary Dwarfism</strong>):</p>\n<ol>\n<li>Normal growth at birth&nbsp;with growth retardation becoming apparent around 1 year of age</li>\n<li><strong>Proportionate short stature</strong></li>\n<li>Hypoglycemic seizures in newborn</li>\n<li>Small larynx with a&nbsp;<strong>high-pitched voice</strong></li>\n<li>Small genitalia (micropenis)</li>\n<li>Delayed skeletal maturation</li>\n<li>Delayed dentition</li>\n<li>Delayed puberty (sexual infantilism)</li>\n<li>Doll-like facial appearance: small, round facies, frontal prominence, depressed nasal bridge (saddle nose), eyes may bulge, underdeveloped mandible and chin, normal head circumference but craniofacial disproportion due to small facies</li>\n<li>Short neck</li>\n<li><strong>Normal intelligence</strong>.</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2401",
      "difficulty": "medium"
    },
    {
      "text": "A child with recurrent UTI comes to OPD for evaluation.The child passes frequent small amounts of urine with burning sensation. Voiding cystourethrography shows unilateral vesicoureteral reflux (VUR). Identify the grade as per image?",
      "choices": [
        {
          "id": 1,
          "text": "Grade 2"
        },
        {
          "id": 2,
          "text": "Grade 4"
        },
        {
          "id": 3,
          "text": "Grade 5"
        },
        {
          "id": 4,
          "text": "Grade 3"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Voiding cystourethrography </strong>shows vesicoureteral reflux of Grade 4, in which contrast media fill and grossly dilate the ureter and the collecting&nbsp; system with blunting of calyces. Some tortuosity of ureter is also present.</p>\n<p>VUR severity is graded is based on the <strong>appearance of the urinary tract on a contrast voiding cystourethrogram</strong>.</p>\n<p>&nbsp;</p>\n<p>&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/df05cd22dab44d2d9474ca95b637208dx787x200.PNG\" alt=\"Explanation Image\"><p><strong>Grading of vesicoureteral reux:</strong></p>\n<ul>\n<li>Grade I: VUR into a non-dilated ureter</li>\n<li>Grade II: VUR into the upper collecting system without dilation</li>\n<li>Grade III: VUR into dilated ureter and/or blunting of calyceal fornices</li>\n<li>Grade IV: VUR into a grossly dilated tortuous ureter</li>\n<li>Grade V: Massive VUR, with significant ureteral dilation and tortuosity and loss of the papillary impression.</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9b6b46dc2b474e58b682ec88babc8370.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4360",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following babies has least risk of developing hypoglycaemia?",
      "choices": [
        {
          "id": 1,
          "text": "A baby born to hypertensive mother taking propranolol"
        },
        {
          "id": 2,
          "text": "Infant of diabetic mothers taking oral hypoglycemic drugs"
        },
        {
          "id": 3,
          "text": "A baby born to hypertensive mother taking methyldopa"
        },
        {
          "id": 4,
          "text": "Infants with birth weight more than 90th percentile"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Infants with hypertensive mother taking methyldopa,a alpha 2 adernergic receptor agonist have the least risk of developing hypoglycaemia.</p>\n<p>Hypoglycemia in newborns</p>\n<p>Blood sugar levels &lt;40mg/dl</p>\n<p>High risk situations where screening is recommended -</p>\n<ul>\n<li>Low birth weight &lt;2000gms</li>\n<li>Preterm infants &lt;35 weeks</li>\n<li>Small for gestational age.birth weight&lt;10<sup>th</sup> percentile</li>\n<li>Infant of diabetic mothers. (insulin dependent and gestational diabetes)</li>\n<li>Large for gestational age infants. birth weight&gt;90<sup>th</sup> percentile</li>\n<li>Infants with Rh haemolytic disease</li>\n<li>Infants with morphological IUGR</li>\n<li>Infants born to mother receiving therapy with terbutaline/propranolol/labetolol/oral hypoglycemic agents.</li>\n<li>Any sick neonate</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4361",
      "difficulty": "medium"
    },
    {
      "text": "A concerned mother brings her 15-day old baby to you with complaints of decreased activity and vomiting. On examination, the baby is hypotensive, has depressed fontanelles and reduced skin turgor. The image of the external genitalia of the baby is shown below. Which electrolyte abnormality can you expect to see in this baby?",
      "choices": [
        {
          "id": 1,
          "text": "Hypokalemia"
        },
        {
          "id": 2,
          "text": "Hyperkalemia"
        },
        {
          "id": 3,
          "text": "Hypocalcemia"
        },
        {
          "id": 4,
          "text": "Hypercalcemia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The image shows <strong>ambiguous genitalia</strong>. This along with signs of <strong>dehydration</strong> and <strong>hypotension</strong> suggest <strong>congenital adrenal hyperplasia</strong> due to <strong>21-hydroxylase deficiency. Hyperkalemia</strong>&nbsp;and hyponatremia (due to mineralocorticoid deficiency) can be seen in this condition.&nbsp;</p>\n<p>These babies present at <strong>10&ndash;14 days of age</strong> with progressive weight loss, weakness, anorexia, vomiting, <strong>dehydration</strong>,<strong> hypoglycemia,&nbsp;and hypotension</strong>.</p>\n<p>Without treatment,<strong> shock</strong>, cardiac arrhythmias, and death may occur within days or weeks.</p><hr><h3>Related Pearl: Variants of Congenital Adrenal Hyperplasia (CAH)</h3><table>\n<tbody>\n<tr>\n<td><strong>21-hydroxylase deficiency</strong></td>\n<td><strong>17-hydroxylase deficiency</strong></td>\n<td><strong>11&beta;-hydroxylase deficiency</strong></td>\n<td><strong>3&beta;-HSD deficiency</strong></td>\n</tr>\n<tr>\n<td>\n<p>Deficiency of cortisol and aldosterone</p>\n</td>\n<td>\n<p>Deficiency of cortisol and sex hormones</p>\n</td>\n<td>\n<p>Deficiency of cortisol</p>\n</td>\n<td>\n<p>Deficiency of cortisol, aldosterone, and testosterone</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&uarr; in testosterone</p>\n</td>\n<td>&uarr; in aldosterone</td>\n<td>&uarr; in deoxycorticosterone (mineralocorticoid) and testosterone&nbsp;</td>\n<td>&uarr; in DHEA</td>\n</tr>\n<tr>\n<td>Salt wasting crises</td>\n<td>Salt retention and&nbsp; hypertension</td>\n<td>\n<p>Salt retention and&nbsp; hypertension</p>\n</td>\n<td>Salt-wasting crises</td>\n</tr>\n<tr>\n<td>Virilization of females (ambiguous genitalia 46XX) &nbsp;&nbsp;&nbsp;</td>\n<td>Failure of sexual development in females at puberty</td>\n<td>Virilization of females&nbsp; (ambiguous genitalia 46XX)</td>\n<td>Females are mildly<br /> virilized (DHEA is a weak androgen)</td>\n</tr>\n<tr>\n<td>Precocious puberty in males</td>\n<td>Males are incompletely virilized (ambiguous genitalia 46XY)</td>\n<td>Precocious puberty in males</td>\n<td>Males are incompletely virilized (ambiguous genitalia 46XY)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note</strong>: In&nbsp;11&beta;-hydroxylase deficiency, aldosterone synthetic capacity is normal and some corticosterone is synthesized from progesterone by intact aldosterone synthase enzyme. Thus, it is unusual for patients to manifest signs of adrenal insufficiency.</p>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8875362964284b4d8aeca0c5054aeea5.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA2151",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is false?",
      "choices": [
        {
          "id": 1,
          "text": "Head circumference should be measured within 24 hours after birth"
        },
        {
          "id": 2,
          "text": "Head circumference equals chest circumference at 1 year of age"
        },
        {
          "id": 3,
          "text": "A boys height at 2 and half years is half of his adult height"
        },
        {
          "id": 4,
          "text": "A girls height at 2 years is half of her adult height"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Head circumference <strong>should not be measured within 24 hours</strong> because the head is subjected to molding during delivery, which makes the measurements unreliable.</p>\n<p>The maximum circumference of the head from the <strong>occipital protuberance</strong> to the <strong>supraorbital ridges</strong> on the forehead is recorded using the&nbsp;cross-tape method.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Head circumference</strong></td>\n</tr>\n<tr>\n<td>At birth</td>\n<td>33 to 35cm</td>\n</tr>\n<tr>\n<td>3 m</td>\n<td>40 cm</td>\n</tr>\n<tr>\n<td>6 m</td>\n<td>43 cm</td>\n</tr>\n<tr>\n<td>1 year</td>\n<td>46 cm</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>48 cm</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>49 cm</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>50 cm</td>\n</tr>\n<tr>\n<td>12 years</td>\n<td>52 cm (adult size)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>Head circumference increases by the following:\n<ul>\n<li>2 cm/month in first 3 months</li>\n<li>1 cm/month in next 3 months</li>\n<li>0.5 cm/month in next 6 months</li>\n</ul>\n</li>\n</ul>\n<p>Head circumference is more than chest circumference by 2.5 cm at birth.</p>\n<ul>\n<li>At birth: <strong>Head circumference</strong> <strong>&gt;</strong> <strong>Chest circumference</strong></li>\n<li>At 9-12 months:&nbsp;<strong>Head circumference = Chest circumference</strong></li>\n<li>After 1 year: Head circumference <strong>&lt;</strong> <strong>Chest circumference</strong></li>\n</ul><p>Interesting fact!</p>\n<p>A boy's height at <strong>2 and half years</strong> is half of his adult height and a girl's height at <strong>2 years</strong> is half of her adult height.</p>\n<p>To roughly predict adult height, use the formula:</p>\n<ul>\n<li><strong>Adult height</strong> = height at 2.5 years for boys (or 2 years for girls) <strong>X 2</strong></li>\n</ul>\n<p>According to WHO growth charts, the height-for-age for most of the children lies between 70-90 cm during these periods. The double of it, i.e. 140-180 cm is the average height that most of us achieve as adults.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1471",
      "difficulty": "medium"
    },
    {
      "text": "Identify the disease shown in the karyotype:",
      "choices": [
        {
          "id": 1,
          "text": "Cri-duchat syndrome"
        },
        {
          "id": 2,
          "text": "Bloom syndrome"
        },
        {
          "id": 3,
          "text": "Angelman syndrome"
        },
        {
          "id": 4,
          "text": "Fragile X syndrome"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In the karyotype, there is a<strong>partial deletion of the short arm of chromosome 5</strong>, which leads to <strong>Cri-du-chat syndrome.</strong>Partial aneuploidyoccurs as a result of the breakdown of the chromosomes.</p>\n<p>Cri-du-chat syndrome is a rare genetic disorder.<strong></strong>Features<strong></strong>of the condition are <strong>hypotonia</strong>,<strong> short stature</strong>, <strong>characteristic cry</strong> called a cat's cry in the first few weeks of life, <strong>microcephaly</strong> with protruding metopic sutures, <strong>hypertelorism</strong>, bilateral epicanthic folds, high arched palate, flat nasal bridge, and <strong>intellectual disability.</strong></p>\n<p>Diagnosis is based on clinical findings and chromosomal analysis.<strong>Fluorescence in situ hybridization</strong> (FISH) is the specific test to confirm the diagnosis.</p>\n<p>Given below is a picture of the facies in cri-du-chat syndrome:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0502276cef0f47aba609aa6b5d3f46bex740x985.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option B: <strong>Bloom syndrome</strong> is a rare autosomal recessive disorder characterized by short stature, sun sensitivity, predeposition of development of cancer, and genomic instability.</p>\n<p>Option C: <strong>Angelman syndrome</strong> is caused due to deletion in the maternal chromosome 15 or by paternal uniparental disomy. It primarily affects the nervous system. Characteristic features are delayed development, intellectual disability, severe speech impairment, and ataxia.</p>\n<p>Option D: <strong>Fragile X syndrome</strong> is a genetic disorder also termed Martin Bell syndrome. It is the most common cause of inherited mental retardation (among the X-linked disorders), intellectual disability, and autism.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f0df819cbf3a4cd0bef5401fcb6063f3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4362",
      "difficulty": "easy"
    },
    {
      "text": "Identify the apparatus used in paediatrics",
      "choices": [
        {
          "id": 1,
          "text": "Electronic weighing scale"
        },
        {
          "id": 2,
          "text": "Resuscitator"
        },
        {
          "id": 3,
          "text": "Radiant warmer"
        },
        {
          "id": 4,
          "text": "Phototherapy unit"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Image shows <strong>Radiant warmer</strong> used to maintain the body temperature of newborn infants.<br />This is done so that the energy expended for metabolic heat production is minimized.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/54152e3d5df84fb4907e7e0bc6e0f03b.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4363",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following fetal hormones does not play any role in fetal growth?",
      "choices": [
        {
          "id": 1,
          "text": "Insulin"
        },
        {
          "id": 2,
          "text": "Glucocorticoid"
        },
        {
          "id": 3,
          "text": "Thyroxine"
        },
        {
          "id": 4,
          "text": "Growth hormone"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Growth hormone</strong> does not play any role in fetal growth, although it is present in high levels during the fetal period. However, it does have a role in the&nbsp;<strong>postnatal period</strong>.&nbsp;</p>\n<p><strong>Insulin</strong> and <strong>thyroxine</strong> hormones are required for normal growth and development during late gestation. <strong>Glucocorticoid</strong> has a role in the prepartum maturation of organs such as liver, lungs, and gastrointestinal tract.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC1402",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is not a component of Polio Endgame Strategy 2019-2023 by WHO?",
      "choices": [
        {
          "id": 1,
          "text": "Stop all circulating vaccine-derived poliovirus (cVDPV) outbreaks within 120 days of detection"
        },
        {
          "id": 2,
          "text": "Separation of polio surveillance and vaccine preventable disease surveillance"
        },
        {
          "id": 3,
          "text": "Certify eradication of Wild Poliovirus (WPV)"
        },
        {
          "id": 4,
          "text": "Interrupt transmission of all wild poliovirus (WPV)"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Integration,&nbsp;</strong>not separation, of polio surveillance with vaccine-preventable disease (VPD) surveillance, is a part of <strong>Polio Endgame Strategy 2019-2023.</strong></p>\n<p><span>Goals of the Polio Endgame Strategy 2019&ndash;2023</span></p>\n<p><strong>Goal One: Eradication </strong></p>\n<ul>\n<li>Interrupt transmission of all wild poliovirus (WPV)</li>\n<li>Stop all circulating vaccine-derived poliovirus (cVDPV) outbreaks within 120 days of detection and eliminate the risk of emergence of future VDPVs</li>\n</ul>\n<p><strong>Goal two: Integration</strong></p>\n<ul>\n<li>Contribute to strengthening immunization and health systems to help achieve and sustain polio eradication</li>\n<li>Ensure sensitive poliovirus surveillance through integration with comprehensive vaccine-preventable disease (VPD) and communicable disease surveillance systems</li>\n<li>Prepare for and respond to future outbreaks and emergencies</li>\n</ul>\n<p><strong>Goal Three: Certification &amp; Containment</strong></p>\n<ul>\n<li>Certify eradication of WPV</li>\n<li>Contain all polioviruses</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2957",
      "difficulty": "medium"
    },
    {
      "text": "The given image shows an infant feeding cup. It is used for feeding ________",
      "choices": [
        {
          "id": 1,
          "text": "Malnourished infant"
        },
        {
          "id": 2,
          "text": "Hypoglycemic infant"
        },
        {
          "id": 3,
          "text": "Normal infant"
        },
        {
          "id": 4,
          "text": "Low birth weight  infants"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Technique shown is <strong>Paladai feeding</strong> technique used for<strong> low birth weight , premature infants</strong>.</p>\n<p>A paladai is a small bowl with a long pointed lip .The advantages of this feeding method are that it usually faster than spoon or even cup feeding and there is less spillage.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b3a9b72ed44443de860194758b5e3c0e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4370",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following does not belong to clinical stage 3 of HIV in children /infants -",
      "choices": [
        {
          "id": 1,
          "text": "Oral hairy leukoplakia"
        },
        {
          "id": 2,
          "text": "Unexplained anemia/neutropenia/thrombocytopenia"
        },
        {
          "id": 3,
          "text": "Persistent oral candidiasis"
        },
        {
          "id": 4,
          "text": "Oesophageal candidiasis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Oesophageal candidiasis</strong> does not belong to clinical stage 3.<br /> Its <strong>stage 4</strong> of HIV in infants.</p><hr><h3>Related Pearl: Clinical stages of HIV in children/ infants</h3><p><strong>Stage 1</strong></p>\n<ul>\n<li><strong>Asymptomatic</strong></li>\n<li>Persistent<strong> generalized lymphadenopathy</strong></li>\n</ul>\n<p><strong>Stage 2</strong></p>\n<p><strong>General-</strong></p>\n<ul>\n<li><strong>Unexplained persistent hepatosplenomegaly</strong></li>\n<li>Recurrent or chronic upper&nbsp;respiratory infections&nbsp;(otitis media, otorrhoea,&nbsp;sinusitis, tonsilitis)</li>\n<li>Fungal nail infections</li>\n</ul>\n<p><strong>Oral-</strong></p>\n<ul>\n<li><strong>Recurrent oral ulcerations</strong></li>\n<li><strong>Unexplained persistent parotid enlargement</strong></li>\n<li>Linear gingival erythema</li>\n</ul>\n<p><strong>Skin-&nbsp;</strong></p>\n<ul>\n<li>Papular pruritic eruptions</li>\n<li>Extensive wart virus infection</li>\n<li>Extensive molluscum contagiosum</li>\n<li><strong>Herpes zoster</strong></li>\n</ul>\n<p><strong>Stage 3</strong></p>\n<p><strong>General-</strong></p>\n<ul>\n<li>Unexplained moderate malnutrition not adequately responding to standard therapy</li>\n<li><strong>Unexplained persistent diarrhea</strong> (14 days or more)</li>\n<li><strong>Unexplained persistent fever</strong> (above 37.6 &deg;C intermittent or constant, for longer than one month)</li>\n<li><strong>Unexplained anemia </strong>(&lt;8 g/dL),<strong> neutropenia</strong> (&lt;0.5 x 10<sup>9</sup>/L)&nbsp;or<strong> chronic thrombocytopenia </strong>(&lt;50 &times; 10<sup>9</sup>/L)</li>\n</ul>\n<p><strong>Oral-</strong></p>\n<ul>\n<li><strong>Persistent oral candidiasis </strong>(after first 6-8 weeks of life)</li>\n<li><strong>Oral hairy leukoplakia</strong></li>\n<li>Acute necrotizing ulcerative gingivitis/periodontitis</li>\n</ul>\n<p><strong>Respiratory-</strong></p>\n<ul>\n<li><strong>Pulmonary TB/ Lymph node TB</strong></li>\n<li>Severe recurrent bacterial pneumonia</li>\n<li><strong>Symptomatic lymphoid interstitial pneumonitis</strong></li>\n<li>Chronic HIV-associated lung disease including bronchiectasis</li>\n</ul>\n<p><strong>Stage 4</strong></p>\n<p><strong>General-</strong></p>\n<ul>\n<li>Unexplained severe wasting, stunting or malnutrition not responding to standard therapy</li>\n<li>Chronic herpes simplex infection; (oro-labial or cutaneous of more than one month's duration or visceral at any site)</li>\n<li><strong>Extrapulmonary TB </strong>and disseminated non-tuberculosis mycobacterial infection</li>\n<li><strong>Kaposi sarcoma</strong></li>\n<li><strong>Oesophageal candidiasis</strong> (or candidiasis of trachea, bronchi or lungs)</li>\n<li><strong>Cytomegalovirus infection</strong>; retinitis or CMV infection affecting another organ, with onset at age over 1 month)</li>\n<li>Disseminated endemic mycosis (extrapulmonary histoplasmosis, coccidioidomycosis)</li>\n<li>Chronic cryptosporidiosis and&nbsp;isosporiasis</li>\n<li><strong>Symptomatic HIV-associated nephropathy </strong>or HIV-associated<strong> cardiomyopathy</strong></li>\n</ul>\n<p><strong>Neurological-</strong></p>\n<ul>\n<li>Central nervous system toxoplasmosis (after one month of life)</li>\n<li>HIV encephalopathy</li>\n<li>Cerebral or B-cell non-Hodgkin lymphoma</li>\n<li>Progressive multifocal leukoencephalopathy</li>\n<li>Extrapulmonary cryptococcosis (including meningitis)</li>\n</ul>\n<p><strong>Respiratory-</strong></p>\n<ul>\n<li><strong>Pneumocystis pneumonia</strong></li>\n<li>Recurrent severe bacterial infections (e.g., empyema, pyomyositis, bone or joint infection, meningitis, but excluding pneumonia)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4371",
      "difficulty": "hard"
    },
    {
      "text": "Match the following congential malformation with its findings -",
      "choices": [
        {
          "id": 1,
          "text": "A-iii   B-iv     C-ii     D-i"
        },
        {
          "id": 2,
          "text": "A -iv    B-iii    C-i    D-ii"
        },
        {
          "id": 3,
          "text": "A-iii     B-iv    C-i   D-ii"
        },
        {
          "id": 4,
          "text": "A-iv      B-iii   C-ii   D-i"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Coffee bean sign is seen in sigmoid volvulus in plain erect xray.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5c5e360f5c2242a1a7d3367c135cf774x1123x1205.JPEG\" alt=\"Explanation Image\"><p>Bird beak sign is seen in achalasia cardia in barium swallow.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/da54df3fa46648598aa7e399aee67b09x319x598.JPEG\" alt=\"Explanation Image\"><p>Double bubble sign is seen in duodenal atresia in plain erect xray abdomen.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/98b3a32b5e614964a5e1165d2593a02ex400x505.PNG\" alt=\"Explanation Image\"><p>Multiple air fluid levels is seen in jejunal and ileal atresia in plain erect xray abdomen.</p><hr><h3>Related Pearl: Radiological findings in various GI disorders</h3><p><strong>Duodenal atresia:&nbsp;</strong>Double bubble sign</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8e78c140797481eb09e4bcef9106cd8x720x910.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Jejunal and ileal atresia:&nbsp;</strong>Multiple air-fluid levels (plain erect X-ray abdomen) presenting as&nbsp;<strong>triple bubble sign.&nbsp;</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9513fa34bce3499088a9a4601ae434c4x834x1186.PNG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Congenital hypertrophic pyloric stenosis: </strong>Single enlarged gastric gas bubble&nbsp;- <strong>single bubble</strong> sign</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/20dd99dfcb3e4ffa8728b296b69b5556x284x383.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Sigmoid volvulus:&nbsp;</strong>Coffee bean sign&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/81240b80138a476d8f5ca2b40d19c68bx490x600.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Achalasia cardia:&nbsp;</strong>Bird-beak sign</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fdcc40d8b70549d4b0c489b623ab32c8x720x1526.PNG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Small bowel obstruction</strong>: The obstructed bowel loops are central in location and show <strong>valvulae conniventes</strong> (mucosal folds that cross the entire diameter of the bowel) characteristic of jejunal involvement.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c32bbb60d2824af6b74fbd5585c9bb98x1279x1662.JPEG\" alt=\"Pearl Image\"><p><strong>Large bowel obstruction</strong>: The presence of <strong>haustrations</strong> is a feature of large bowel obstruction. Haustral folds are irregular and do not cross the entire diameter of the bowel. These are absent in the caecum.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6bf0090dbba54d08bf6d460f3f8c3a01x1279x1642.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Caecal volvulus</strong>: Presence of caecal dilatation, single air-fluid level extending into the left upper quadrant, and absence of gas in the distal colon. The colonic haustrations are well maintained.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cee8aa378b1148b198c0d8a7c9f23822x720x608.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Midgut volvulus</strong>: Corkscrew appearance showing the duodenum and jejunum spiraling around the mesenteric vessels in upper GI contrast studies.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/300e1080a96d4fe19194df39a503fef0x660x476.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Necrotizing enterocolitis (NEC)</strong>: Abdominal X-ray findings include pneumatosis intestinalis (air in the bowel wall).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/13531a6af0434a64bf763df3a4c61fb8x479x600.JPEG\" alt=\"Pearl Image\"><p><strong>Cystic fibrosis</strong> (CF): Abdominal x-ray with contrast enema reveals a microcolon with several meconium plugs.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d13f1689c1141ed93c2e447931546f0x512x683.PNG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://daily-rounds-staging.s3.amazonaws.com/uploads/2f55afca76714aba837864e316b434c5.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4372",
      "difficulty": "easy"
    },
    {
      "text": "A child starts saying -mama, baba at this age the social development seen is -",
      "choices": [
        {
          "id": 1,
          "text": "Waves bye bye"
        },
        {
          "id": 2,
          "text": "Stranger anxiety"
        },
        {
          "id": 3,
          "text": "Mimicry"
        },
        {
          "id": 4,
          "text": "Recognises mother"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Mama, Baba are bisyllables which is language milestone at age of 9 months at this age social development seen is child waves bye bye.</p><hr><h3>Related Pearl: Language milestones</h3><div>\n<table><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td><strong>Age</strong></td>\n<td><strong>Milestone</strong></td>\n</tr>\n<tr>\n<td>1 month</td>\n<td>Alerts to sound</td>\n</tr>\n<tr>\n<td>2 months</td>\n<td>Coos (musical vowel sound)</td>\n</tr>\n<tr>\n<td>4 months</td>\n<td>Laughs aloud</td>\n</tr>\n<tr>\n<td>6 months</td>\n<td>Monosyllables sounds (ma, ba)</td>\n</tr>\n<tr>\n<td>9 months</td>\n<td>Bisyllables (mama, baba)</td>\n</tr>\n<tr>\n<td>12 months</td>\n<td>1-2 words with meaning</td>\n</tr>\n<tr>\n<td>18 months</td>\n<td>8-10 word vocabulary</td>\n</tr>\n<tr>\n<td>2 years</td>\n<td>2-3 word sentences (uses pronouns like I, me, you)</td>\n</tr>\n<tr>\n<td>3 years</td>\n<td>Asks questions and knows name and gender</td>\n</tr>\n<tr>\n<td>4 years</td>\n<td>Sings songs, poems and tells stories</td>\n</tr>\n<tr>\n<td>5 years</td>\n<td>Asks meaning of words</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div><hr><h3>Related Pearl: Social and adaptive milestones</h3><table><caption>&nbsp;</caption>\n<tbody>\n<tr>\n<td>\n<div><strong>Age</strong></div>\n</td>\n<td>\n<div><strong>Milestone</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div>2 months</div>\n</td>\n<td>\n<div>Social smile</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3 months</div>\n</td>\n<td>\n<div>Recognizes mother</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>6 months</div>\n</td>\n<td>\n<div>Stranger anxiety</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>9 months</div>\n</td>\n<td>\n<div>Waves bye-bye</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>12 months</div>\n</td>\n<td>\n<div>Comes when called</div>\n<div>Plays simple ball game</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>15 months</div>\n</td>\n<td>\n<div>Jargon</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>18&nbsp;months</div>\n</td>\n<td>\n<div>Copies parents in the task</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>2 years</div>\n</td>\n<td>\n<div>Asks for food, drink, toilet</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>3 years</div>\n</td>\n<td>\n<div>Shares toys</div>\n<div>Knows full name and gender</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>4 years</div>\n</td>\n<td>\n<div>Plays cooperatively in a group and goes to the toilet alone</div>\n</td>\n</tr>\n<tr>\n<td>\n<div>5 years</div>\n</td>\n<td>\n<div>Helps in household tasks and can dress and undress on its own</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4373",
      "difficulty": "medium"
    },
    {
      "text": "A postnatal  period of life which provide the platform for remarkable growth and development,setting the trajectory for a child's life-",
      "choices": [
        {
          "id": 1,
          "text": "Newborn"
        },
        {
          "id": 2,
          "text": "Infancy"
        },
        {
          "id": 3,
          "text": "Toddler"
        },
        {
          "id": 4,
          "text": "Preschool child"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A postnatal period of life which provide the platform for remarkable growth and development,setting the trajectory for a child's life is the first year of life that is infancy.</p>\n<p>First four weeks after birth is newborn.It is the time for marked physiologic transitions occuring in all organ systems, and the newborn infant learn to respond to many forms of external stimuli.</p>\n<p>1-3 years postnatal is toddler.It's newly found ability to walk allows separation and independence.</p>\n<p>Preschool is 3-6 years of age .The emergence of language and exposure of children to an expanding social sphere represent the critical milestone</p><hr><h3>Related Pearl: Periods of growth</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Prenatal period</strong></td>\n</tr>\n<tr>\n<td>Zygote</td>\n<td>0 to 14 days of gestation</td>\n</tr>\n<tr>\n<td>Embryo</td>\n<td>3 weeks to 8 weeks</td>\n</tr>\n<tr>\n<td>Fetus</td>\n<td>9 weeks to birth</td>\n</tr>\n<tr>\n<td>Perinatal period</td>\n<td>22 weeks to 7 days after birth</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Postnatal period</strong></td>\n</tr>\n<tr>\n<td>Newborn (neonate)</td>\n<td>First 4 weeks after birth</td>\n</tr>\n<tr>\n<td>Infancy</td>\n<td>The first year</td>\n</tr>\n<tr>\n<td>Toddler</td>\n<td>1 to 3 years</td>\n</tr>\n<tr>\n<td>Preschool child</td>\n<td>3 to 6 years</td>\n</tr>\n<tr>\n<td>School-age child</td>\n<td>6 to 12 years</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Adolescence</strong></td>\n</tr>\n<tr>\n<td>Early</td>\n<td>10 to 13 yr</td>\n</tr>\n<tr>\n<td>Middle</td>\n<td>14 to 16 yr</td>\n</tr>\n<tr>\n<td>Late</td>\n<td>17 to 19 yr</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4374",
      "difficulty": "hard"
    },
    {
      "text": "A final year student is asked to give a seminar on 'fetal circulation.' Which among the following statement told by him in the seminar is likely to be false?",
      "choices": [
        {
          "id": 1,
          "text": "Heart receives blood with high oxygen saturation"
        },
        {
          "id": 2,
          "text": "Pressure in right and left ventricles are equal"
        },
        {
          "id": 3,
          "text": "Liver receives blood with low oxygen saturation compared to the brain"
        },
        {
          "id": 4,
          "text": "Blood in inferior venacava has lower oxygen concentration compared to superior venacava"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Blood in the inferior vena cava has a&nbsp;<strong>higher</strong> oxygen concentration compared to the superior vena cava.</p>\n<p>The superior vena cava carries the deoxygenated blood from the upper part of the body to the right atrium. The&nbsp;<strong data-stringify-type=\"bold\">highly oxygenated blood</strong>&nbsp;is carried to the fetus from the placenta via the<strong data-stringify-type=\"bold\">&nbsp;umbilical vein&nbsp;</strong>with 50% of the umbilical venous blood entering the hepatic circulation and the rest bypassing the liver and joining the inferior vena cava (IVC) via the ductus venosus. Hence, the blood in the inferior vena cava has a <strong>higher</strong> oxygen concentration compared to the superior vena cava. Also, relatively a larger percentage of oxygen-rich blood is perfused to the brain.</p>\n<p>Pressures in both the right and left ventricles are equal in a developing fetus. The upper part of the body is perfused exclusively by the left ventricle while the lower extremities are perfused by the right ventricle.&nbsp;</p><hr><h3>Related Pearl: Concepts of Fetal Circulation</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c5f5c613865d4d4c83b9f14b09d6af27x1280x2558.JPEG\" alt=\"Pearl Image\"><p><strong>Concept 1:</strong></p>\n<p>Oxygenated blood from placenta to the&nbsp;fetus via the left umbilical vein.</p>\n<p><strong>Concept 2:</strong></p>\n<p>Most of the umbilical venous blood shunts via the&nbsp;<strong>ductus venosus</strong> to the inferior vena cava and gets mixed with deoxygenated blood from the&nbsp;lower part of the&nbsp;body and liver.</p>\n<p><strong>Concept 3:</strong></p>\n<p>One-third of blood from the inferior vena cava is directly pumped to the left atrium across the&nbsp;<strong>foramen ovale</strong>; then to the left ventricle;&nbsp;and ejected from there into the ascending aorta, where it supplies the upper body and the brain.</p>\n<p><strong>Concept 4:</strong></p>\n<p>A major portion of blood enters the right ventricle, mixes with blood from the superior vena cava, and ejects into the pulmonary trunk.</p>\n<p><strong>Concept 5:</strong></p>\n<p><strong>Ductus arteriosus</strong> bypasses the lungs, and hence, a major portion pumps into the descending aorta to perfuse the lower part of the&nbsp;body and the umbilical arteries carry blood to the&nbsp;placenta for oxygenation.</p>\n<p><span><strong>&nbsp;</strong></span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ed455606f546467ab69c6b4580153829x1280x2558.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3296",
      "difficulty": "medium"
    },
    {
      "text": "A mother comes with her 3 month  child asking the physician if she can feed her child with cereal. What problem can this lead to ?",
      "choices": [
        {
          "id": 1,
          "text": "Allergy due to food content"
        },
        {
          "id": 2,
          "text": "Risk of gastrointestinal infection"
        },
        {
          "id": 3,
          "text": "Retarded oro-motor development"
        },
        {
          "id": 4,
          "text": "Contaminated food leading to reflux"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Babies should receive only breast milk or infant formula for the first 6 months of life.<br /> Most important reason for this is <strong>allergy due to food content.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4375",
      "difficulty": "hard"
    },
    {
      "text": "A teacher complains that a 7-year-old girl with falling grades is inattentive in class and has unresponsive episodes with staring. On hyperventilation, her symptoms increase and her EEG findings show a 3Hz spike and wave discharge. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Myoclonic seizures"
        },
        {
          "id": 2,
          "text": "Myoclonus"
        },
        {
          "id": 3,
          "text": "Typical Absence seizure"
        },
        {
          "id": 4,
          "text": "Juvenile myoclonic epilepsy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The most likely diagnosis based on the clinical vignette and <strong>EEG features</strong> is<strong> typical absence seizures</strong>.</p>\n<p>Absence seizures are a form of <strong>generalized seizures</strong> marked by <strong>unresponsiveness</strong>, <strong>staring</strong>, and eye flutter which usually last for a few seconds.<strong>GABA<sub>B</sub>receptors, T-type Ca<sup>2+</sup>channels</strong>, and<strong>K<sup>+</sup>channels</strong>situated within the <strong>thalamus</strong>are involved in the pathophysiology of absence seizures.</p>\n<p>It is of two types:</p>\n<ul>\n<li>Typical absence seizures</li>\n<li>Atypical absence seizures</li>\n</ul>\n<p>Typical absence seizures are associated with <strong>3-Hz spike</strong> and <strong>slow wave discharges</strong> on EEG. It usually starts by the age of <strong>5-8 years</strong> and can occur up to a <strong>hundred times</strong> per day.<strong> Hyperventilation</strong> can precipitate seizures and EEG changes. They last only for a <strong>few seconds</strong> and do not have an aura. It can be accompanied by eyelid flutter or upward rolling of the eyes. <strong>Simple automatisms</strong> such as lip smacking or picking at clothing can also be seen. There is <strong>no postictal period</strong> and the child usually <strong>resumes whatever activity</strong> he/she was engaged in prior to the episode.</p>\n<p><strong>Atypical absence seizures</strong>are associated with <strong>1-2-Hz spike-and-slow-wave discharges</strong>. Head atonia and <strong>myoclonus</strong> can also be seen during the seizures. It is precipitated by <strong>drowsiness</strong> and is generally more difficult to treat.</p>\n<p><strong>Juvenile absence seizures</strong> occur at a later stage and are similar to typical absences. It is marked by 4-to-6 Hz spike-and-slow-wave and polyspike-and-slow-wave discharges. It is associated with juvenile myoclonic epilepsy.</p>\n<p><strong>EEG</strong>is the<strong> diagnostic test </strong>forabsence seizures. An <strong>MRI</strong> would appear normal and so is not useful.<strong>Ethosuximide</strong>is the drug of choice for typical absence seizures. Its mechanism of action is<strong>inhibition</strong>of<strong>T-type calcium channels</strong>.<strong>Phenytoin, carbamazepine</strong>, and<strong>oxcarbazepine</strong>have all been associated with<strong>aggravation </strong>of<strong> absence seizures</strong>and even<strong>absence status epilepticus</strong>in children with absence epilepsy.</p>\n<p>The<strong></strong>followingepilepsy syndromes are associated with absence seizures:</p>\n<ul>\n<li><strong>Childhood absence epilepsy</strong></li>\n<li><strong>Juvenile absence epilepsy</strong></li>\n<li><strong>Juvenile myoclonic epilepsy</strong></li>\n<li><strong>Myoclonic absence epilepsy</strong></li>\n<li><strong>Lennox-gestaut syndrome</strong></li>\n</ul>\n<p>Other options:</p>\n<p>Option A: <strong>Myoclonic seizures</strong> can be focal, multifocal, or generalized. It is marked by the <strong>rapidity</strong> of jerks (&lt;50 mseconds). EEG changes depend on the type of myoclonic seizure.</p>\n<p>Option B: <strong>Myoclonus</strong> is very brief, abrupt, and involuntary jerky contractions of a single muscle or muscle group. Some causes of myoclonus in children include hiccups (physiologic), <strong>meningitis</strong>, and<strong> electrolyte disturbances</strong>.</p>\n<p>Option D: <strong>Juvenile myoclonic epilepsy</strong> also known as <strong>Janz syndrome</strong> is a type of generalized epilepsy seen in young adults. It presents as myoclonic jerks in the morning and generalized tonic-clonic or clonic-tonic-clonic seizures upon awakening. <strong>Sleep deprivation</strong> and photic stimulation can precipitate the episodes. <strong>4-5 Hz polyspike-and-slow-wave discharges</strong> can be seen on EEG.</p><hr><h3>Related Pearl: First-line Agents in Different Types of Seizures</h3><table>\n<tbody>\n<tr>\n<td><strong>Type of seizure&nbsp;</strong></td>\n<td><strong>1st-line antiepileptic drugs</strong></td>\n</tr>\n<tr>\n<td>\n<p>Focal seizures&nbsp;</p>\n</td>\n<td>\n<ul>\n<li>Carbamazepine</li>\n<li>Oxcarbazepine&nbsp;</li>\n<li>Lamotrigine</li>\n<li>Levetiracetam</li>\n<li>Phenytoin</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>GTCS&nbsp;</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate</li>\n<li aria-level=\"1\">Levetiracetam&nbsp;</li>\n<li aria-level=\"1\">Lamotrigine&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Typical absence seizures&nbsp;</td>\n<td>\n<ul>\n<li><strong>Ethosuximide&nbsp;</strong>(drug of choice)</li>\n<li>Sodium valproate</li>\n<li>Lamotrigine</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Atypical absence seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\">Sodium valproate&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Myoclonic seizures</td>\n<td>\n<ul>\n<li aria-level=\"1\"><strong>Sodium valproate</strong> (drug of choice)</li>\n<li aria-level=\"1\">Lamotrigine</li>\n<li aria-level=\"1\">Topiramate</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/101872b202064d2cb7b92bcc2e363cc4.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC4376",
      "difficulty": "easy"
    },
    {
      "text": "A child in your unit is receiving treatment for chronic diarrhea. His diet history is remarkable for a high phytate-rich diet. His labs reveal low serum zinc. Which of the following findings is least likely to be seen in this child?",
      "choices": [
        {
          "id": 1,
          "text": "Dwarfism"
        },
        {
          "id": 2,
          "text": "Incomplete development of gonads"
        },
        {
          "id": 3,
          "text": "Dermatitis of extremities"
        },
        {
          "id": 4,
          "text": "Predominant impairment of humoral immunity"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical vignette is suggestive of&nbsp;<strong>chronic zinc</strong>&nbsp;deficiency. Zinc deficiency affects both cell-mediated and humoral immunity. The&nbsp;<strong>cell-mediated immunity</strong>&nbsp;is impaired predominantly, as <strong>zinc</strong> is essential for T-cell division, maturation, and differentiation.&nbsp;</p>\n<p>In a child with a&nbsp;<strong>phytate-rich</strong>&nbsp;diet, a chronic deficiency of zinc and iron usually co-exist. Isolated chronic zinc deficiency can be seen in the setting of a child suffering from&nbsp;<strong>chronic diarrhoea</strong>, repeated pneumonia or chest infections, and congenital malabsorption disorders.</p>\n<p>Chronic zinc deficiency manifests as:</p>\n<ol>\n<li>Dwarfism</li>\n<li>Hypogonadism</li>\n<li>Dermatitis of extremities and around orifices</li>\n<li>T-cell immunodeficiency</li>\n<li>Diarrhoea&nbsp;</li>\n</ol>\n<p>The features of acute zinc deficiency include:</p>\n<ol>\n<li>Decreased growth</li>\n<li>Poor wound healing&nbsp;</li>\n<li>Diarrhea</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA0465",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following cardiac lesions are expected in the patient seen in the image?",
      "choices": [
        {
          "id": 1,
          "text": "Aortic regurgitation"
        },
        {
          "id": 2,
          "text": "Coarctation of the aorta"
        },
        {
          "id": 3,
          "text": "VSD"
        },
        {
          "id": 4,
          "text": "ASD"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This is a patient with a<strong>webbed neck</strong>, seen typically inTurners syndrome.</p>\n<p><strong>Turners syndrome:</strong></p>\n<ul>\n<li>Also known as Ullrisch- Turner syndrome or <strong>Gonadal dysgenesis</strong>  Caused by absence of set of genes from the short arm of X chromosome ( 45XO )</li>\n<li>Breast development is absent with ovarian failure and primary or secondary amenorrhea.</li>\n<li>Lymphadema, short stature</li>\n<li>Low set ears, low hairline and webbed neck</li>\n<li>Horse shoe kidney</li>\n<li>Cardiac manifestations  <strong>Coarctation of aorta</strong>, bicuspid aortic valve</li>\n<li>Treatment  GH, Estrogen replacement therapy</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/dc936e0da19143d59f433666de254391.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA9994",
      "difficulty": "easy"
    },
    {
      "text": "A 3 yr old male child with left flank pain is diagnosed to have an acute UTI. On USG, the left ureter was found to be duplicated. The most probable site of the opening of ectopic ureter will be?",
      "choices": [
        {
          "id": 1,
          "text": "Prostatic urethra"
        },
        {
          "id": 2,
          "text": "Seminal vesicle"
        },
        {
          "id": 3,
          "text": "Ejaculatory duct"
        },
        {
          "id": 4,
          "text": "Trigone of bladder"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Opening of the ectopic ureter in male (most to least common)&nbsp;:</p>\n<ul>\n<li><strong>Posterior urethra (prostatic) above the external sphincter</strong></li>\n<li>Seminal vesicle</li>\n<li>Prostatic utricle</li>\n<li>Ejaculatory duct</li>\n<li>Vas deferens</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB0019",
      "difficulty": "medium"
    }
  ]
}